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ABSTRACT
The class of polycyclic hydrocarbons including adamantane, pentacyclo [5.4.0.02,6.
03,IO.05,9]undecane (PCU) and trishomocubane have proven to be an exciting investigation
for synthetic chemists. Many derivatives have been shown to possess excellent antiviral
and antibacterial properties, as well as potent anti-Parkinson agents. Some improve the
lipophilic nature of biologically active drugs, while others affect the three-dimensional
structure of peptides once incorporated as amino acid analogues.
This investigation focussed on deriving routes to improve yields of racemic 4-amino-(D3)-
trishomocubane-4-carboxylic acid (tris-amino acid), the synthesis of enantiomerically pure
tris-amino acid, the incorporation of tris-amino acid into a short peptide, as well as the
simulation of the rearrangement of PCU to trishomocubane by using computational tools.
Research into developing a more efficient hydrolysis of trishomocubane-hydantoin (tris-
hydantoin) to yield racemic tris-amino acid, led to the development of two novel
compounds: the mono-Boc [Novel Compound 1, (NC1)] and bis-Boc [Novel Compound
2, (NC2)] protected hydantoin. Base hydrolysis of NC2 quantitatively yielded the racemic
tris-amino a~id, which was a significant improvement on previously documented synthetic
routes.
The first attempt to produce enantiomerically pure tris-amino acid was through the
synthesis of diastereomeric derivatives of tris-hydantoin, chromatographic separation of the
diastereomers, followed by base hydrolysis of the hydantoin ring to produce
enantiomerically pure tris-amino acid. This research led to the development of two novel
N-protected tris-hydantoin derivatives (NC3 and NC4). Failure to chromatographically
separate the diastereomers resulted in the abandonment of this particular route.
The use of enzymes was, therefore, attempted to produce enantiomerically pure tris-amino
acid. A novel ester derivative of tris-amino acid (NC5) was synthesised, which was
followed by the application of Pig Liver Esterase (PLE). PLE is an enzyme which cleaves
ester functionalities. Some success was achieved but the extremely low yields of
enantiomerically pure tris-amino acid did not warrant this enzyme as a viable route for
production of the desired product.
Solid phase techniques were employed for the production of a tripeptide consisting of
alanine-glycine-tris-amino acid (ala-gly-tris). Some difficulty was encountered in
extending the amino acid sequence due to suspected Schiff base interaction between the
free amino group of tris-amino acid and the carbonyl functionality of glycine in the second
position.
A computational study, using ab initio methods, was performed on the rearrangement of the
PCU diol to 7-fluoro-ll-hydroxy-trishomocubane. Two mechanisms (Proposed Mecha-
nism 1 and Proposed Mechanism 2) were explored and both showed that the
stereochemistry of the hydroxyl groups has only a marginal influence on the transition state
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CHAPTERl
INTRODUCTION
The word protein is derived from the Greek word proteios, which means first. This is an
appropriate name considering that proteins are primary building blocks for all life on earth.
l
Proteins are fundamental to all living cells as they are principal components of enzymes,
hormones, antibodies and tissue.
Proteins are polymers of natural a-amino acids, which, except for glycine, contain at least
one chiral centre.t A chiral molecule cannot be superimposed upon its mirror image
(enantiomers, Fig. 1.1, No. 1.1 and 1.2). Those amino acids with chiral centres can
naturally co-exist as enantiomers (R or S configuration) since they possess identical










Figure 1.1: Enantiomers of serine
Amino acids found in eukaryotic organisms are mainly of the S-configuration.
2
This is key
information to a chemist involved in asymmetric synthesis, since only one enantiomer of
the synthesised racemate is likely to be biologically active. This is the challenge that has
encouraged synthetic organic chemists to develop techniques that afford enantiopure
molecules.
3
In 1820 glycine was first isolated from gelatin hydrolyzates.
4
In the 100 years that
followed, the remaining 20 essential amino acids, which are normally found in proteins,
were isolated. Since 1956 well over 500 naturally occurring amino acids have been
identified due to the improvement of detection and elucidation techniques.4 There has also
been extensive research into the asymmetric synthesis of non-natural amino acids since
many have shown capacity to modify the biological activity of medicinally important
peptides and have also been used extensively in the field of peptidomimetics.s,6 One
example is the asymmetric synthesis of various substituted prolines. They have been used
to alter the conformational behaviour of flexible, small peptides as well as inhibit
angiotensin converting enzyme (ACE).6 ACE is a metalloprotease, which plays a vital role
t A chiral centre is a carbon atom with four different groups attached.
2
in blood pressure regulation.6,7 Captopril, which is an oral drug containing an enantiopure
derivative of proline, has been successful in reducing blood pressure and preventing heart
failure through the inhibition of ACE activity (Fig. 1.2).6 ACE is involved in cleaving off a
dipeptide from the inactive decapeptide, angiotensin I, to give the biologically active
octapeptide, angiotensin n. This peptide is involved in activating various systems that lead
to increasing blood pressure. Captopril inhibits the actions of ACE, therefore, not allowing
the production of angiotensin n (Fig. 1.2).
I














retention of Na+ and H20
Figure 1.2: Role of angiotensin converting enzyme in regulating blood pressure
The synthetic organic chemistry research group of the University of Natal, Durban (UND)
has followed suit in this growing field of non-natural amino acid synthesis.
The incorporation of cage molecules into various drugs has proven to aid biological
activity.8,9,10,1l l-Aminoadamantane, also known as amantadine (Fig. 1.3, No. 1.4), has
proven to be an effective antiviral and anti-Parkinson agent,12 Adamantanine (Fig. 1.3, No.
1.5) has displayed success as a biologically active species, with the capacity to reduce
transport of methionine and leucine into Ehrlich ascites carcinoma cells in vitro.8,B There
have also been reports of polycyclic cage hydrocarbons improving lipophilicity, therefore,
h . d d . 11 1 9 14 15en ancmg rug an IOn transport across ce u ar membranes." A computational study,
involving Ramachandran plots of short peptides containing a non-natural cage amino acid,
3
has suggested that the bulky cage is likely to influence secondary folding of the peptide.16
This synthetic study may contribute towards a mechanical synthetic tool to modify the
three-dimensional structure of proteins.
16
Our long term goal is to enhance the
understanding of the manipulation of the three-dimensional structure of peptides and








Figure 1.3: Structures of amantadine and adamantanine
Our research group is actively involved in asymmetric synthesis, solid phase peptide
synthesis, and computational studies of polycyclic cage derivatives. The group pays
particular attention to the chemistry of pentaclclo[5.4.0.02,6.03,1O.05,9]undecane (PCU, Fig.
1.4, No. 1.6) and pentacyclo[6.3.0.02,6.03,IO.O ,9]undecane (trishomocubane, Fig. 1.4, No.
1.7) and their amino acid derivatives, since various cage amino derivatives have been cited











Figure 1.4: Structure of pentacyclo[S.4.0.02,6.03,1O.OS,9]undecane and
trishomocubanet
This project had four aims: (a) to improve the synthesis of racemic 4-amino-(D3)-
trishomocubane-4-carboxylic acid (tris-amino acid), (b) to synthesise enantiopure tris-
amino acid, (c) to incorporate racemic tris-amino acid into a short peptide, and (d) to
perform a computational investigation on the rearrangement of the PCU skeleton to
trishomocubane.
*The numbering system for trishomocubane was adopted from the paper published by Dekker et ai,
Journal ojOrganic Magnetic Resonance., 1981, 15, 188-192.
4
Many researchers have reported synthetic routes to afford enantiopure trishomocubane and
various derivatives thereof,21,22 yet before a recent study,23 there has been no attempt to
synthesise tris-amino acid. Govender reported the successful synthesis of racemic tris-
amino acid.
23
Research was, therefore, also undertaken to synthesise enantiopure tris-
amino acid through the chromatographic separation of diastereomers, as well as the use of





Pentacyclo[6.3.0.02,6.03,IO.05,9]undecane (trishomocubane) was first reported by Eaton et al.
in 1968, as a keto-derivative.24 Two years later, Ramamoorthy and Underwood were
successful in synthesising the underivatised C 11H I4 polycyclic hydrocarbon, which they










Trishomocubane can be regarded as a molecule of six fused, equivalent cyclopentane
rings.25 It is the only C 11H I4 pentacycle that does not contain highly strained three or four
membered rings, and is a rare organic molecule belonging to the point group D/6
Trishomocubane possesses three C2 axes of symmetry (through each of the methylene
groups and the centre of the opposite C-C bond), as well as an axis of symmetry passing
through C2 and C9 . It is also a chiral molecule.
25
Trishomocubane can, therefore, be
termed a gyrochiral molecule.
21
This describes the symmetry of a shape which is chiral but
not asymmetric and of the point groups Cn (n:;t:l), Dn, T, 0 and 1.
27
The D3 symmetry of the
cage ensures only two enantiomers for a quaternary substituted carbon instead of the usual












.. .. Normally diastereomers if not D3 symmetry
Figure 2.2: "Diastereomers" of the quaternary substituted carbon of
trishomocubane
Empirical force field calculations using Allinger and Engler force-fields predicted
trishomocubane to possess the greatest stability over any of the other C tt H14 isomers.
28
,29
It is, for example, 10 kcal mor) (M!) more stable than the PCV skeleton (also C ttHI4),
making PCV an excellent starting material for the synthesis of trishomocubane (Table
2.1)26,28 since the rearrangement is exothermic.
Table 2.1: Force-field calculations for PCU and trishomocubane at 25 °C28,29
AHr .::\Hr Strain energy Strain energy
(kcal mOrl) (kcal mOrl) (kcal mOrl) (kcal mOrl)
Compound Engler Allinger Engler Allinger
trishomocubane 3.38 11.32 42.05 44.13
(1.7)
PCV (1.6) 19.62 21.93 52.29 54.74
Rearrangement of PCV to trishomocubane is thought to occur via a 1,2 alkyl shift of an
intermediate secondary cation (Fig. 2.3)?6 It is not clear from the literature whether the












Figure 2.3: Rearrangement of 2.4 to trishomocubane
Kent et al. used force field calculations to predict the stability of various D3-trishomocubyl
cations (Fig. 2.3, No. 2.6) with respect to the aluminium bromide catalysed rearrangement
of PCV to trishomocubane.
26
Cations at Cl, C3, C4, C6, were predicted to be unfavourable.
A cation at C9 was predicted to be not prohibitively strained but all possible 1,2 alkyl shifts
involving an initial carbocation at C9 lead to products with four membered rings. A cation
at the CS/Cl I position was the thermodynamically most suitable position predicted, being
the energetically most favourable, as well as the only 1,2 alkyl shift that did not result in the
formation of a four membered ring.
26
The above mentioned results were reported for the
AlBr3 catalysed bromination in carbon disulfide. The synthesis yielded trishomocubane
(93 %), 2,4-ethanonoradamantane (5 %) and 2,8-ethanonoradamantane (2 %). There are
many alternative routes for the synthesis of trishomocubane, such as the Wolff-Kishner
reduction of PCV with sodium, in diethylene glyco1.
26
This synthesis also afforded
unwanted side products due to the strain energy associated with the PCV molecule.
Treatment of the PCV diol with hydriodic acid (HI) also leads to cage rearrangement,
resulting in 7-iodo-trishomocuban-4-01.
26
The mechanism for this rearrangement is more
closely studied in Chapter 6, using computational tools.
Dekker et al. reported, through isotopic labelling experiments, that the rearrangement does
not proceed exclusively via migration of the 1,7 bond as expected?O They did not offer a
mechanism for the unexpected result and did not seem to report a follow-up study as they
indicated.3o There is, however, universal agreement that trishomocubane is the current
8
C 11 H 14 stabilomer, which is the isomer that possesses the greatest thermodynamic stability
at 25 QC in the gas phase.
26
By 1970, when Ramamoorthy and Underwood had synthesised and reported
trishomocubane, biological applications for adamantane derivatives had already been
discovered.
l1
They foresaw a similar future for their C11H I4 hydrocarbon. Their vision has
become reality, with various trishomocubane derivatives exhibiting potential
pharmacological properties
13
as well as possible solar energy storage systems?1
As an example of the biological importance of trishomocubane derivatives, Oliver et al.
synthesised various 4-amino-(D3)-trishomocubane derivatives.
13
These were tested as
potential anticataleptic and anticholinergic agents. Many of the derivatives displayed
promising results. One derivative (Fig. 2.4, No. 2.9) in particular, exhibited equipotency to
amantadine (known anti-Parkinson agent) with regard to anticataleptic activity as well as
mild anticholinergic activity.13 It also displayed excellent activity against Influenza A2.
An analogous compound (Fig. 2.4, No. 2.10) displayed activity against Herpes Simplex





Figure 2.4: Biologically active derivatives of trishomocubane13
There has also been a great deal of research involving the incorporation of cage compounds
into short peptide sequences. Many peptides containing non-proteinogenic or non-natural
, 'd h b d h'b' b' I 'I " 5673233 .ammo aCl save een reporte to ex 1 It 10 oglca activity. ' '" The mcorporation of
adamantyl cage amino acids into short peptides has yielded very promising results with
regard to biological activity.lO The incorporation of tris-amino acid (Fig. 2.5, No. 2.13)
into a short peptide may also prove to be a candidate for biological testing. Synthesis of the
tris-amino acid involved numerous, well documented reactions, therefore, the work
presented in this chapter deals with the synthesis of tris-amino acid, the starting material for
the peptide work presented in Chapter 5.
The synthesis of the tris-amino acid (Fig. 2.5, No. 2.13) was achieved via a Bucherer-
B 23,34 'f' h b .ergs conversIOn 0 tns omocu anone (FIg. 2.5, No. 2.11) to its corresponding













amino acid (Fig. 2.5, No. 2.13).23 This method was previously successfully applied to
35 36





Figure 2.5: Bucherer-Bergs synthesis and hydantoin hydrolysis
The synthesis of trishomocubane began with the synthesis of the PCU skeleton, followed
by cage rearrangement to yield the desired product. The PCU skeleton was synthesised in a
two step Diels-Alder reaction. First, 5,8-methano-4a,5,8,8a-tetrahydro-l A-naphthoquinone
(adduct, Fig. 2.6, No. 2.17) was synthesised via a slow Diels-Alder reaction between
cyclopentadiene (Fig. 2.6, No. 2.14) and p-benzoquinone (Fig. 2.6, No. 2.15)?7
9
0 0 *
~ G'-"" "toluene I ,, i• I II •-20°C .......... I
0 0
2.14 2.15 2.16 2.17
Figure 2.6: Synthesis of 5,8-methano-4a,5,8,8a-tetrahydro-l,4-naphthoquinone
(adduct, Spectra 1_3)38
The adduct was, subsequently, dissolved in 10 % Clv) acetone in hexane solution and
placed in direct sunlight. It was previously believed that photochemically induced
intramolecular [2+2] cyclisation of compound 2.18 (Fig. 2.7) yielded pentacyclo
10








Figure 2.7: Synthesis of pentacyclo[5.4.0.02,6.03,1O.Os,9]undecane-8-11-dione via a
classical, concerted [2+2] photocyclisation (dione, Spectra 4-6)
Recent ab initio investigations, however, have discovered that the cyclisation of the adduct
proceeds via a stepwise diradical mechanism, through a triplet excited state rather than a
concerted [2+2] cycloaddition (Fig. 2.8).41
[~{ r~q'2.21 (first singlet)















Figure 2.8: Ab initio calculated mechanism for adduct cyclisation41
Synthesis of trishomocubanone from the dione (Fig. 2.9, No. 2.19) involved protection of
the free ketone via ketal formation for the purpose of mono-keto reduction in the following
synthetic step. Ketal protection was achieved by refluxing (Dean and Stark apparatus) with
1,2-ethanediol and p-toluenesulfonic acid in toluene.42,43 The proximity of the two keto
groups of (2.27) ensured mono protection due to steric hindrance. Even with excess 1,2-
11
ethanediol (I: 1.5), only the mono protected dione (Fig. 2.9, No. 2.33) was obtained. Note,
that it is well established44,45 that nucleophilic attack on the ketone groups of the peo
skeleton will almost exclusively occur from the exo face (Fig. 2.10). The mechanism of
conversion to pentacyclo[5.4.0.02,6 .03,lo.05,9]undecane-8-11-dione-monoethylene ketal

























Figure 2.10: Nucleophilic attack on the keto functional group of cage systems
The keto-ketal (Fig. 2.11, No. 2.33) was dissolved in ethanol and the free ketone reduced
with sodium borohydride. This resulted in the formation of Il-hydroxy-
pentacyclo[5.4.0.02,6.03,1O.05,9]undecane-8-one-ethylene ketal (hydroxy-ketal, Fig. 2.11, No.









Figure 2.11: Synthesis of the hydroxy-ketal (Spectra 10_12)38
The successful reduction of the ketone allowed removal of the ketal protective group in the
next synthetic step to reintroduce the former keto functional group. Hydrolysis of the ketal
was achieved through the addition of a 10 % Clv) HCI solution, yielding Il-hydroxy-
pentacyclo[5.4.0.02,6.03,lo.05,9]undecane-8-one (hydroxy-ketone, Fig. 2.12, No. 2.40).43






Figure 2.12: Synthesis of the hydroxy-ketone (Spectra 13_15)46
The subsequent synthetic step involved the reduction of the keto functional group to a
methylene functional group. This was achieved through refluxing (Fig. 2.13, No. 2.40)
with hydrazine hydrate in diethylene glycol, and subsequent addition of excess KOH
(Modified Huang-Minlon conditions).43 Removal of volatile products from the high
boiling diethylene glycol was achieved via steam distillation, which yielded endo-


















Figure 2.13: Synthesis of the endo_pentacyclo[5.4.0.02,6.03,lO.OS,9] undecane-8-o1
38(Spectra 16-18)
15
At this stage rearrangement of the PCU alcohol to trishomocuban-4-ol was possible. This
was achieved through the dissolution of the alcohol (Fig. 2.14, No. 2.46) in glacial acetic
acid and concentrated sulphuric acid, followed by reflux conditions. The acidic medium
induced rearrangement of the PCU skeleton to yield trishomocubane as an acetate
derivative (Fig. 2.14, No. 2.49). The acetate was carried directly to the next step.
Dissolution of the crude acetate in methanol and potassium carbonate, with subsequent
stirring at room temperature for 24 hours, hydrolysed the acetate to yield trishomocubane-
4-01 (Fig. 2.14, No. 2.52 and 2.53).43 The PCU diol can also be induced to rearrange to
trishomocubane through the use of hydriodic acid (HI).43 It follows a very similar



















Figure 2.14: Synthesis of trishomocubane-4-ol (Spectra 19-21)
16
At this stage it was necessary to convert the alcohol back to a ketone as this was required
for subsequent hydantoin formation (Bucherer-Bergs). The alcohol (Fig. 2.15, No. 2.53)
was oxidised using the lones oxidation to yield pentacyclo[6.3.0.02,6.03,IO.OS,9]undecanone












Figure 2.15: Synthesis of trishomocubanone (Spectra 22_24)38
The monoketone (Fig. 2.16, No. 2.55) was subjected to the Bucherer-Bergs method for
hydantoin formation, the precursor to the target amino acid. The reaction conditions for the
conversion of the monoketone were optimised by Govender,23 who first reported the
synthesis of tris-hydantoin (Fig. 2.16, No. 2.12). The hydantoin was synthesised as a
racemate due to the possible SN2 attack of the nitrile group from both sides of the Sp2
hybridised keto functional group. It is, therefore, important to note that although the
hydantoin is represented as one enantiomer in the following illustrations, it is in fact a
racemic mixture. The mechanism of hydantoin formation, as proposed by Bucherer34 is















Figure 2.16: Synthesis of tris-hydantoin proposed by Bucherer 34
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Figure 2.16: Continuation of the synthesis of tris-hydantoin proposed by
34Bucherer (Spectra 25-32)
The above proposed mechanism seems feasible, although the structure (2.61) is not clearly
understood. There is, however, speculation of an alternative mechanism as from the















Figure 2.17: Alternative proposed§ mechanism for the synthesis of tris-
hydantoin
The mechanism proposed in Fig. 2.17 is more likely since the imine (2.60) is readily
hydrolysed to a carbonyl compound in aqueous acidic solution. The conversion of
intermediate (2.63) to the hydantoin (2.12) is analogous to the synthesis of phthalamide




successfully synthesised tris-hydantoin (2.12), it was not structurally
elucidated. This prompted efforts to fully elucidate the hydantoin through the use of one-
and two-dimensional nuclear magnetic resonance (NMR) spectroscopy.
The successful synthesis of tris-hydantoin was first evident from the infrared spectrum
(Spectrum 31), with the presence of two carbonyl absorption bands at 1766 and 1720 cm-I
and a N-H absorption band at 3314 cm-I. The correct molecular ion peak of rn/z 231
[M+Ht in the mass spectrum (Spectrum 32) was also confirmation of tris-hydantoin. The
presence of two D20 exchangeable proton peaks at 7.88 ppm and 10.54 ppm in the 'H
§ Mechanism proposed by the author of this dissertation, T Raasch.
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NMR spectrum (Spectrum 25) was evidence of the amide (Hr) and imide (H3') protons of
the hydantoin ring respectively. The l3C NMR spectrum (Spectrum 26) enabled a quick
review of the molecule, with the presence of a characteristic amide carbonyl signal at
177.50 ppm (C4,) and an urea carbonyl group at 157.05 ppm (C2,),36,39 the eight methine
carbons of the cage between 39.57 and 55.67 ppm and the presence of two methylene
carbons at 32.95 and 33.49 ppm. Two-dimensional NMR techniques were essential for the
full elucidation of the tris-hydantoin molecule.
The numbering system of tris-hydantoin and the novel derivatives thereof were adopted
from the numbering system used by Dekker et al. during their structural elucidation of
trishomocubanol and trishomocubanone.
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The C4 carbon of the cage was assigned to 73.48 ppm in the l3C NMR spectrum due to it
being an integral part of the electron withdrawing hydantoin system. This assignment was
confirmed by the absence of heteronuclear single quantum coherence (HSQC) correlations
(Spectrum 29), and visible heteronuclear multiple bond coherence (HMBC) correlations
(Spectrum 30) with HI' of the hydantoin ring. The C3 and Cs carbons were assigned as the
next most downfield shifted carbons (54.82 and 55.67 ppm) due to their direct attachment
to the deshielded C4 carbon. At this point it was essential to confirm other functional
groups of the cage before it was possible to more accurately assign the C3 and Cs carbons,
but at least it was possible to deduce their proton peaks to the region 1.90-1.98 ppm in the
HSQC spectrum.
The positions of NHI' and 0 4, oxygen with respect to the trishomocubane skeleton were
determined next. This would assist with the elucidation of the rest of the cage skeleton.
The positions of NHI' and 0 4, were chosen as indicated in Fig. 2.17.
The position of NHI' and 0 4, with respect to the cage skeleton were confirmed from the
nuclear Overhauser effect spectroscopy spectrum (NOESY, Spectrum 28) of 2.64.
Correlations of NHI' were observed with four proton signals, which should be H2, H3, Hs
and H6. Oxygen 0 4, should, therefore, be pointing towards protons H9 and H IO . The
strongest NOESY interaction of NHI' should be with the nearest neighbouring proton
(largest spot on the NOESY spectrum - correlation at 7.88 ppm with 2.45 ppm).
The extreme downfield shifted methine proton at 2.84 ppm in the I H NMR spectrum was
assigned to the carbon peak at 42.75 ppm in the HSQC spectrum. This proton peak could
have represented H6 or H IO due to their close spatial proximity to the hydantoin ring. The
HIO proton was confirmed to be the closest to the C4, carbonyl by measuring the bond
distances between the cage methine protons and the various functionalities of the hydantoin
ring of an optimised model of tris-hydantoin (Fig. 2.18, No. 2.64).** The tris-hydantoin
was optimised using density functional theory (OFf) at the B3LYP level of theory, using a
6-31 +G(d) basis set. The hydantoin ring interacts through space with these protons and
causes considerable deshielding of these two protons. The proton closest to the hydantoin
ring in the PCU hydantoin analogue also experienced similar deshielding.36 This
•• A more detailed description of computational chemistry is presented in Chapter 6.
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assignment to either H6 or HID was confirmed by HMBC correlations with C4. The pr~ton
was eventually successfully assigned to HID due to the absence of NOESY correlatIOns
(Spectrum 28) with HI',
H 3 -.. 04' =3.62 A
Hs -.. 04' =3.34 A
H9 -.. °4, =3.15 A
H IO-..°4, = 2.48 A
Figure 2.18: DFT optimised tris-hydantoin
The assignment of HID allowed the assignment of H6 to 2.45 ppm in the IH NMR spectrum
due to visible NOESY correlations with HI' of the hydantoin ring. At this point it was
evident from the NOESY correlations of H6 and HID with the relevant methylene functional
groups of the cage that the peaks between 1.19-1.27 ppm and 1.36-1.39 ppm represented
both H7 and H II protons. A more accurate assignment was achieved at a later stage, but
first it was important to successfully assign the H3 and Hs protons of the cage. The H3
methine proton was assigned to 1.97 ppm in the correlation spectroscopy (COSY) spectrum
(Spectrum 27) due to correlations with HID. This allowed assignment of Hs to 1.91 ppm in
the COSY spectrum. It was now possible to make a more accurate elucidation of the two
methylene groups. The proton peaks 1.19-1.22 ppm in the IH NMR spectrum were
22
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assigned to H Ils due to NOESY correlations with H3. The proton peaks 1.24-1.27 ppm
were assigned to H7s due to NOESY correlations with Hs.
The H2 methine proton was assigned to 2.18 ppm in the COSY spectrum due to correlations
with H3 and H6. This allowed the assignment of HI to 2.10 ppm in the COSY spectrum due
to correlations with H2 and Hlls. The Hg methine proton was assigned to 2.13 ppm in the
COSY spectrum due to correlations with Hs and H IO. This allowed the Hg methine proton,
which was the last unassigned methine proton of the cage, to be assigned to 2.10 ppm in the
COSY spectrum. This was confirmed by NOESY correlations with both the H7 and HI1
methylene protons.
Since the H7s proton had already been assigned, it was possible to assign H7a to 1.36-1.39
ppm in the COSY spectrum due to correlation with H6. The previous assignment of H IIs
also allowed the assignment of HIla to 1.36-1.39 ppm in the COSY spectrum due to
correlation with H IO. These assignments were confirmed by Dekker et al., who reported
that the methylene protons of trishomocubanol and trishomocubanone are significantly
coupled to only one of the vicinal protons
30
. They reported coupling between H6-H7a, H IO-
Hila, HI-H lls and Hg-H7S.30 These coupling assignments are in agreement with the above
reported couplings. These assignments completed the structural elucidation of tris-
hydantoin.
The rest of the carbon atoms were assigned through correlation with the established proton
signals using the HSQC spectrum. A summary of the NMR data is available in Table 2.2.






The next synthetic step in pursuit of tris-amino acid involved hydrolysis of the hydantoin
ring (Fig 2.19, No. 2.12), resulting in the racemic tris-amino acid (Fig. 2.19, No. 2.13,
Spectrum 33). The hydrolysis required harsh conditions (1.25 M NaOH, 170°C).23 The
amino acid was precipitated from the basic medium by adjusting the pH to the approximate
isoelectric point (pH 6.5) using concentrated hydrochloric acid. Previous work had
determined the PCD-amino acid's isoelectric point as pH 6.5.39 This has not been
determined for tris-amino acid, yet from experimental results the amino acid precipitated
from the aqueous solution between pH 6.5-7.0. The Fmoc derivative was subsequently
prepared in order to compare NMR data to authentic spectra that had previously been


















Figure 2.19: Synthesis of tris-amino acid (2.13) and Fmoc-tris-amino acid (2.65)
The poor yields (-60%) of amino acid obtained in the above-mentioned hydrolysis of tris-
hydantoin prompted a search for a more efficient method of hydrolysis. Rebek48 modified
a method that hydrolysed lactams and secondary amides49 and developed an efficient, facile
method for hydrolysis of a,a-disubstituted hydantoins. It has been postulated that
hydrolysis of mono and disubstituted hydantoins proceeds via different mechanisms.5o
Rebek's method involved Boc protection of the amide and imide nitrogens on the
hydantoin ring, followed by lithium hydroxide aided hydrolysis at room temperature. Boc
24
protection enables milder hydrolysis conditions due to the carbonyl groups becoming more
h · b l' 48susceptible to nucleophilic attack, and converts t e mtrogens to etter eavmg groups.
Rebek's method of Boc addition to the hydantoin ring was applied to the pre-synthesised
tris-hydantoin. It was clearly visible from the NMR data that the method only resulted in
the monoprotected hydantoin [Novel Compound 1, (NC1), Fig. 2.20, No. 2.66]. Addition
had also, surprisingly, occurred on the imide nitrogen (N3,). The imide nitrogen is
positioned between two electron withdrawing carbonyl functional groups. One would,
therefore, expect this nitrogen to be far more electron deficient and 'hang-on' to its proton
far more than the corresponding amide nitrogen (N I0). The attachment of the Boc group to
N3' may have been due to steric hindrance from the cage, which did not energetically favour

















Figure 2.20: Novel Compound 1 (NC1, Spectra 37-44)
The previous structural elucidation of tris-hydantoin was essential in elucidating the
structure of NCl (Fig. 2.20, No. 2.66) since a similar method was used to identify the
various functional groups. It was possible to assign all the relevant carbons and protons of
the cage and hydantoin system by following the logic described for the elucidation of tris-
hydantoin. A more detailed description is available in the experimental section (Chapter
8). Confirmation of the Boc group is, however, presented in the following paragraph.
It was evident that the Boc derivative of the tris-hydantoin had been synthesised with the
appearance of three carbonyl peaks in the I3C NMR spectrum (Spectrum 38) and the
appearance of the expected molecular ion peak of rn/z 331 [M+Ht in the mass spectrum
(Spectrum 44). The presence of a proton peak (1.56 ppm) in the1H NMR spectrum
(Spectrum 37), which integrated to nine protons could, therefore, be assigned to the three
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methyl groups (Hs') of the Boc group. The absence of the imide proton (HT) at about 10
ppm and the presence of the amide proton (HI') at 6.40 ppm in the IH NMR spectrum was
evidence that the Boc group had attached to the imide nitrogen. The assignment of the HI'
proton to 6.40 ppm in the IH NMR spectrum was later confirmed by NOESY correlation
(Spectrum 40) with the H6 methine proton of the cage. The CT carbon of the Boc group
was assigned to 85.31 ppm in the HMBC spectrum (Spectrum 42) due to correlation with
the Hs' methyl protons. A more comprehensive assignment of the NC1 functionalities is
available in the experimental section (Chapter 8).
In an attempt to add a Boc functional group to both the amide and imide nitrogens of the
hydantoin ring, a method published by Hammer et al. 51 for derivatising the hydantoin ring
of a,a-disubstituted amino acids was applied to tris-hydantoin. It was similar to Rebek's
method, except triethylamine was also added to the reaction mixture. The electrophilic
nature of the base aided in activating the amide nitrogen (Nr) for derivatisation, enabling
the bis-Boc derivative [Novel Compound 2, (NC2), Fig. 2.21, No. 2.67] to be successfully
synthesised.
2.67
Figure 2.21: Novel Compound 2 (Spectra 45-52)
Although NC2 could not be fully structurally elucidated due to major overlap of the NMR
signals, it was evident that NC2 had been synthesised due to the presence of four carbonyl
groups present in the l3C NMR spectrum (Spectrum 46). The absence of the amide and
imide hydrogens of the hydantoin ring at -6 and -10 ppm, respectively, in the IH NMR
spectrum (Spectrum 45), and the presence of the expected molecular ion peak of m/z 431
[M+Ht in the mass spectrum (Spectrum 52), further supported the presence of two Boc
groups. This was further supported by the presence of two proton peaks in the IH NMR
26
spectrum, that each integrated to the mne protons of the methyl groups on the Boc
functionality.
Due to the absence of the HI' proton, a different strategy was employed for elucidating the
structure of NC2 from that which was previously used for tris-hydantoin and NCt.
Previous assignments of the methylene groups during the elucidation of tris-hydantoin and
NCt, as well as reported couplings between the methylene protons and their respective
vicinal protons of trishomocubanol and trishomocubanone,30 proved to be a helpful starting
point in analysing the two-dimensional NMR spectra of NC2.
The C4 carbon of NC2 was easily recognisable at 76.55 ppm in the HSQC spectrum
(Spectrum 49) as it displayed no HSQC correlations. It was also expected to be the most
downfield shifted cage carbon due to its direct attachment to the electron withdrawing
hydantoin ring. The next most downfield shifted carbons (54.03 and 58.15 ppm) were
assigned to either C3 or Cs due to their direct attachment to C4. Through HSQC
correlations their protons were located at either 2.16-2.17 or 2.52-2.53 ppm. A more
precise assignment was only possible at a more advanced stage of NC2 elucidation.
The next stage of elucidation relied on the previous assignments of the methylene (H7a, H7s,
HIla, H11s) protons of tris-hydantoin and NCt as well as the reported couplings between
H6(H IO) and H7a(Hlla) and between H\(Hg) and Hlls(H7s) of trishomocubanol and
trishomocubanone.
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This allowed the assignment of the downfield shifted proton peak at
3.12 ppm in the COSY spectrum (Spectrum 47) to be assigned to the H IO methine proton.
This was due to correlations with the Hila proton at 1.44-1.46 ppm. The H6 (2.28 ppm), HI
(2.09-2.13 ppm) and Hg (2.14-2.15 ppm) methine protons were assigned due to
corresponding COSY correlations with H7a (1.46-1.48 ppm), H I1s (1.27-1.30 ppm) and H7s
(1.30-1.33 ppm) protons respectively.
This allowed the assignment of H2 to 2.38-2.40 ppm in the COSY spectrum due to
correlation with HI. Similarly the H3 proton was assigned to 2.52-2.53 ppm in the COSY
spectrum due to correlation with H2, which is one of the predicted shifts for H3 mentioned
above. This allowed the assignment of Hs to 2.16-2.17 ppm, the other predicted shift
mentioned above. This was confirmed by visible COSY correlation with H6. This led to
the assignment of the last methine proton, H9 of the cage to 2.29 ppm due to COSY and
NOESY correlations (Spectrum 48) with H IO.
The C7 carbon was assigned to 33.02 ppm due to HMBC correlations (Spectrum 50) with
Hs, and CII to 32.94 ppm due to HMBC correlation with C2. The H 12, protons of the Boc
group were assigned to 1.53 ppm in the NOESY spectrum due to correlation with H2 and
H6, therefore, allowing the Hg, Boc protons to be assigned to 1.55 ppm. This led to the
assignment of CT to 86.11 ppm in the HMBC spectrum due to correlation with Hg,. The
HMBC correlation between H 12, and the carbon peak at 84.95 ppm allowed this carbon
peak to be assigned to C1I '. The C4' carbonyl was assigned to 169.58 ppm in the l3C NMR
spectrum, while the C2' carbonyl was assigned to 145.74 ppm due to more electron
delocalisation from NI' and N3' at C2,. Based on the same analogy the Cs' and C9, carbonyl
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groups were assigned to 149.67 and 149.03 ppm respectively. A more comprehensive
description of NC2 is available in the experimental section (Chapter 8).
Rebek's method of hydrolysis of the hydantoin ring was applied to NC2.48 This involved
addition of lithium hydroxide (8 mole equivalents) in aqueous solution, followed by stirring
at room temperature overnight. Adjustment of the pR to 6.5 resulted in precipitation of the
amino acid. The product was obtained by filtration and washed successively with deionised
water, acetone and diethyl ether. This method quantitatively resulted in the tris-amino acid
(Fig. 2.22, No. 2.13), which was confirmed through successful synthesis of the Fmoc
derivative. The NMR data was identical to authentic data.
23
This method proved to be a
milder method of hydantoin hydrolysis, with improved yields, despite the additional step.
The base hydrolysis of tris-hydantoin, which was reported by Govender,23 only resulted in
a 60 % yield of tris-amino acid. The base hydrolysis of the bis-Boc derivative of tris-
hydantoin, which is reported in this dissertation, resulted in a 100 % yield of tris-amino
acid.
Two novel derivatives (NCl and NC2) of tris-hydantoin were synthesised during an
attempt to improve the yield of tris-amino acid from the base hydrolysis of tris-hydantoin.
The base hydrolysis (LiOR) of NC2 quantitatively yielded tris-amino acid, which was a
significant improvement in yield compared to the yields reported by Govender.23 A

































Solid phase peptide synthesis using tris-amino acid has, thus far, only involved the racemic
amino acid23 since synthesising enantiomerically pure tris-amino acid has proven to be a
formidable task. An attempt was, therefore, made in this study, to produce enantiopure tris-
amino acid through the separation of diastereomeric trishomocubane derivatives.
Stereoisomers that are not mirror images of each other are called diastereomers
l (Fig. 3.1).
Since they are not mirror images of each other, they may differ in all properties, whether
chiral or achira1.
52
Diastereomers may differ in melting point, boiling point and solubility,
therefore, sometimes be separable by fractional distillation or fractional crystallisation. l
Differences in molecular shape and polarity results in a difference in adsorption, which may



















Figure 3.1: Example of diastereomers
Tris-hydantoin already possesses nine chiral centres and is one synthetic step from the
amino acid (NaOH hydrolysis). Attaching an enantiopure starting material possessing one
29
chiral centre to the hydantoin ring would produce diastereomers of tris-hydantoin. This, in
principle, could afford chromatographic separation of the resulting diastereomers, and
could ultimately lead to the isolation of enantiopure tris-amino acid.
A route was devised to prepare the corresponding chloroformic ester (Fig. 3.2, No. 3.6)
from R-(-)-2-butanol (Fig. 3.2, No. 3.5). This would be added onto the hydantoin ring of









*= closest chiral centres to form potentially
separable diastereomers
Figure 3.2: Strategy to produce diastereomers of tris-hydantoin
It was hoped to separate the diastereomers by using column chromatography since it is a
less expensive technique compared to preparative high performance liquid chromatography
(HPLC). Once separated, the side chain would be removed by methods similar to those
used to cleave Boc groups (TFA or HN03).52,53 Hydrolysis of the hydantoin ring would
result in enantiomerically pure tris-amino acid.
A common method to form chloroformate esters from alcohols is the use of phosgene gas
or triphosgene [bis(trichloromethyl)carbonate, Fig. 3.3, No. 3.8].54 Triphosgene is a white,
crystalline solid that is soluble in common organic solvents such as dichloromethane,
tetrahydrofuran, ether and chloroform. Many diverse applications have been discovered for
triphosgene, the safe cogener of phosgene gas55 (Table 3.1).
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Table 3.1: Uses of bis(trichlorometh l)carbonate
Uses of tri hos ene
Preparing acid chlorides and anhydrides from carboxylic acids
Chlorination of 1° and 2° alcohols to alkyl chlorides
Preparing chloroformic esters from alcohols
Protecting diols, aminols and thiols
Esterification of amino acids and mono acids








The procedure for chloroformate formation was first tested with isopropanol due to the cost
of enantiopure alcohols. The chloroformic ester (Fig. 3.3, No. 3.12) was prepared via slow,
cannular addition of dry pyridine to an ice-cooled, stirred solution of isopropanol,
triphosgene and dry THF under nitrogen gas. The reaction mixture was subsequently
filtered, under nitrogen gas, into an ice-cooled, stirred solution of tris-hydantoin in dry




















t-= position of new chiral centre
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Figure 3.3: Synthesis of Novel Compound 3 (NC3)
It was hoped that the attack of the chloroformate would be on the amide nitrogen (N \,) of
the hydantoin ring (Fig. 3.3, No. 3.13), resulting in the chiral centres being separated by
only three atoms when applying the chiral chloroformate. The attachment of the
32
chloroformate to the imide nitrogen (N3,) of the hydantoin ring would result in the
separation of the chiral centres by four atoms. The greater the distance between chiral
centres, the less probability of separating the diastereomers. NMR studies ultimately
revealed that attack had taken place on the imide nitrogen, resulting in Novel Compound 3
















Figure 3.4: Novel Compound 3 (NC3)
It was evident from the IH NMR spectrum (Spectrum 53) that attack had been on the imide
nitrogen due to the presence of the amide proton (Hd at 6.98 ppm. The presence of three
carbonyl peaks in the l3C NMR spectrum (Spectrum 54) and the molecular ion peak of rn/z
331 [M+Ht in the mass spectrum (Spectrum 60) was evidence of product formation. The
proton peaks at 1.35 and 1.36 ppm in the IH NMR spectrum (Hg,) integrating to six protons,
and the multiplet at 5.15 ppm of the HT proton was also evidence that the product had been
formed. The assignment of Hg, was confirmed by COSY correlations (Spectrum 55) with
the H9' methyl protons.
The various NMR spectra for NC3 were very similar to those of tris-hydantoin and NCt
(Chapter 2), which was useful in assigning the peaks of this novel compound. The same
strategy for elucidating the structure of tris-hydantoin and NCl was used to fully elucidate
the structure of NC3. A more detailed description is available in the experimental section
(Chapter 8). Note, the H7s proton peaks are obscured by the Hg, proton peaks between
1.35-1.36 ppm in the IH NMR spectrum. The HI and Hg proton peaks are indistinguishable
and their respective carbons are represented by a single peak (46.74 ppm) in the l3C NMR
spectrum.
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Although attack had unexpectedly taken place on the imide nitrogen (N3'), the chiral
chloroformate was still prepared and added to tris-hydantoin. It was hoped that separation
of the diastereomers would still be possible, despite the chiral centres being separated by
four atoms (Fig. 3.3, No. 3.13). The method used by Hammer et al.51 was also used in an
attempt to add the chiral chloroformate to the amide nitrogen of tris-hydantoin but it was
not successful.
The procedure used to synthesise [chlorocarbonic acid-((-)(R)-sec-butyl ester), Fig. 3.2,
No. 3.6] from R(-)-2-butanol (Fig. 3.2, No. 3.5), and the subsequent addition to tris-
hydantoin, was identical to that used for the preparation NC3. This yielded Novel
Compound 4 [(NC4), Fig. 3.5, No. 3.15].
3.15
Figure 3.5: Novel Compound 4 (NC4)
It was evident that NC4 had been synthesised by the presence of the expected molecular
ion peak of m/z 331 [M+Ht in the mass spectrum (Spectrum 68) and the presence of three
carbonyl peaks in the l3e NMR spectrum (Spectrum 62). The appearance of the amide
proton (H1') of the hydantoin ring at 7.19 ppm, and the absence of the imide proton (H3') at
-10 ppm in the IH NMR spectrum (Spectrum 61), was evidence that the chloroformate
had added onto the imide nitrogen.
The various NMR spectra for NC4 were very similar to those of tris-hydantoin, NCl and
NC3, which was useful in assigning the peaks of this novel compound. The same strategy
for elucidating the structure of tris-hydantoin, NC1, and NC3 was used to fully elucidate
the structure of NC4. A more detailed description is available in the experimental section
(Chapter 8). Note, the H7s proton peaks are obscured by the HT proton peaks between
1.32-1.35 ppm in the IH NMR spectrum. The HI and Hs proton peaks are indistinguishable
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and their respective carbons are represented by a single peak (46.73 ppm) in the l3C NMR
spectrum.
The C2' (171.50 ppm) and C4' (152.62 ppm) carbons of the hydantoin ring were assigned
with the same reasoning used for the elucidation of tris-hydantoin, NCl and NC3. Hence,
the Cs' carbonyl carbon was assigned to the peak at 147.74 ppm in the l3C NMR spectrum.
The Hs' protons were assigned to 5.00 ppm from HMBC correlation (Spectrum 66) with
CS" The HT methyl protons were assigned to 1.32-1.35 ppm in the COSY spectrum
(Spectrum 63) due to correlation with the Hs' proton. This allowed the assignment of the
methyl protons(HIO') to 0.94-0.99 ppm in the IH NMR spectrum, which integrated to three
protons. The H9' methylene protons were lastly assigned to the multiplet at 1.60-1.75 ppm
in the COSY spectrum due to correlation with HIO'. A more complete summary of the
NMR data is provided in the experimental section (Chapter 8).
The l3C results provided convincing evidence that diastereomers were present. The carbon
centres closest to the chiral centres and including the chiral centres (C3, C4, Cs, CT and C9,)
exhibited two carbon peaks. This was expected considering diastereomers may differ in
NMR shifts, and peaks closest to the diastereomeric chiral centres would be split in the l3C
NMR spectrum. Numerous attempts to separate the diastereomers by thin layer
chromatography and column chromatography failed, thus, this particular route to produce
enantiomerically pure tris-arnino acid was abandoned. Future work should attempt to
generate diastereomers where the chiral centres are not so far apart.
Although this particular project failed, the synthetic investigation resulted in two novel tris-
hydantoin derivatives (NC3 and NC4). There are also alternative routes for the synthesis
of enantiopure tris-amino acid. Chapter 4 deals with the use of enzymes for the synthesis
of enantiopure tris-amino acid.
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CHAPTER 4
APPLICATION OF ENZYMES TO CAGE SYSTEMS
Enzymes are catalytic proteins, which regulate the chemistry of cells and organisms.
58
A
catalyst is a substance which increases the rate of a chemical reaction, without itself being
changed in the overall process. To date, there are over 2000 known enzymes, with an
enzyme available for most organic reactions.59,60 There are currently several hundred
commercially available enzymes and they are often very expensive. The cost should in no
way demotivate a chemist once the numerous advantages of enzyme-catalysed reactions are
fully recognised. Enzymes are usually very versatile and catalyse a broad spectrum of
reactions and often operate under mild conditions (room temperature and neutral pH). This
minimises problems of isomerisation, racemisation and rearrangement. Many are highly
efficient catalysts, generally very specific with respect to structure and stereochemistry of
substrate and product.59 Unfortunately, enzymes might, therefore, be substrate specific and
would not work for all available analogous substrates.
The role of a catalyst is to lower the energy of activation (Ea) of a reaction, and ultimately
induce a faster reaction58 (Fig. 4.1). This is often achieved by the catalyst nursing the
reacting molecule into a conformation that resembles the transition state, but is of lower
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Figure 4.1: Energetics of an enzyme-catalysed versus a non-enzyme catalysed
reaction
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An enzyme binds the substrate into a region called the active site to form an enzyme-
substrate complex58 (Fig. 4.2). This is usually a pocket or cleft surrounded by amino acid
side chains that either help bind the substrate or play a role in catalysis. The specific
stereochemistry of the pocket accounts for the specificity of the enzyme and is often
alluded to as a lock and key mechanism
2
(Fig. 4.2). The enzyme not only demands a
specific substrate but also demands the substrate to be distorted into an orientation that
resembles its transition state. This is the induced fit hypothesis proposed by Daniel
Koshland in 1958.
2
Induced fit also implies distortion of the enzyme, which may be
localised at the active site, or may also demand a major change in the enzyme's
conformation? Once the catalytic process is complete, the enzyme releases the substrate
and returns to its original state, ready for another round of catalysis (Fig. 4.2).
en,yme.,urrn.. <omolex products













enzyme can be reused
Figure 4.2: Lock and key mechanism
According to Marchand,61 many enzymes fail to catalyse cage-related substrates. Despite
this lack of success, it was decided to pursue an enzyme-catalysed reaction on a
trishomocubane substrate with the hope of some positive results. There was an obvious
choice of two types of enzymes with regard to their application to the various
trishomocubane derivatives. Hydantoinase62 could have been applied to tris-hydantoin to
hydrolyse one enantiomer of the hydantoin, resulting in an enantiomerically pure form of










Figure 4.3: Hydrolysis of tris-hydantoin by hydantoinase enzyme62
Pig liver esterase (PLE), the alternative choice of enzyme, has the ability to hydrolyse
esters, resulting in a free carboxylic acid group (Fig. 4.4, No. 4.9). Since PLE was readily
available in the laboratory, it was decided to test this enzyme on an ester derivative of
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trishomocubane. It was, therefore, necessary to synthesise such a derivative. Researchers
have reported some success with the application of PLE to a,a-disubstituted a-amino acid
esters, which falls in the same category of compounds as an ester derivative of






Figure 4.4: PLE catalysed hydrolysis of ester substrate63
The tris-a-amino acid ester [Novel Compound 5, (NC5), Fig. 4.5, No. 4.10] was
synthesised by the addition of tris-amino acid to ethanol and thionyl chloride under reflux
conditions. The structure was fully elucidated before it was used as a PLE substrate. It was




Figure 4.5: Novel Compound 5 (NC5)
It was evident that NC5 had been synthesised due to the [M+Ht peak of rn/z 234 in the
mass spectrum (Spectrum 76), the presence of the carbonyl peak (C2) at 175.74 ppm in the
l3C NMR spectrum (Spectrum 70), and the D20 exchangeable proton at 1.80 ppm in the
IH NMR spectrum (Spectrum 69) arising from the amino group (Hr). The multiplet at
4.12-4.18ppm in the IH NMR spectrum, which could be assigned to the downfield shifted
methylene group (H4,) of the ester was further evidence of successful ester synthesis.
The C4 carbon was assigned to 69.07 ppm in the HSQC spectrum (Spectrum 73) due to the
absence of HSQC correlations and also because it is the most deshielded carbon due to its
proximity to the carbonyl functionality. The next most deshielded carbons of the cage
(54.04 and 56.20 ppm) were recognised as C3 or Cs due to their direct attachment to C4.
The HMBC correlation (Spectrum 74) of HIla (1.37-1.39 ppm, the splitting patterns of the
cage methylene protons were identical to those seen for tris-hydantoin) with the carbon
38
peak at 56.20 ppm allowed this peak to be assigned to C3. A similar correlation was visible
between H7a (1.39-1.42 ppm) and CS. HSQC correlations, therefore, allowed the
identification of the H3 proton at 1.94-1.95 ppm, and the Hs proton at 2.07-2.10 ppm. The
H6 proton was identified at 2.60 ppm in the COSY spectrum (Spectrum 71) due to
correlation with Hs. This assignment was confirmed by the visible NOESY correlation
(Spectrum 72) with the N I' protons as well as COSY correlations with both the H7a and H7s
(1.30 ppm) protons. The C6 carbon (45.30 ppm) was identified due to HMBC correlation
with H7a.
The H2 proton (2.15-2.18 ppm) was identified due to NOESY correlation with H6 and
HMBC correlation with Cs. The assignment of H2 allowed the assignment of H IO (2.10-
2.11 ppm) due to NOESY correlation with H3. The C IO carbon was distinguished from the
C6 carbon due to HMBC correlation with the Hila proton. The H, proton (2.10-2.11 ppm)
was assigned from the COSY correlations with both the Hila and HI's (1.30 ppm) protons.
It was, unfortunately, not possible to assign its carbon peak to either 46.92 or 46.96 ppm
due to indistinguishable correlations. The Hs proton (2.10-2.11 ppm) was assigned from
NOESY correlations with both the H7 and H" methylene protons. Its carbon peak,
however, was indistinguishable from the C, carbon peak due to reasons mentioned above.
The last unassigned methine proton of the cage (Hg, 2.12-2.15 ppm) was identified from the
COSY correlation with Hs. The H4' (4.12-4.18 ppm) protons were correctly assigned due to
COSY correlations with the Hs' methyl protons. A more detailed elucidation of NC5 is
available in the experimental section (Chapter 8).
Pig Liver Esterase (PLE) is a serine hydrolase, which catalyses the hydrolysis of a wide
range of ester structures.
64
Hydrolytic enzymes are one of the most useful class of enzymes
as they possess broad substrate specificities, are usually highly stereoselective in their
catalysis, do no require expensive and unstable co-enzymes, and are often stable in organic
d d
" 6San aqueous me la.
Previously, PLE posed a few problems to chemists as the enzyme's stereochemistry

























Figure 4.6: Stereochemistry reversals exhibited by PLE
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If an enzyme is to be universally approved as a routine catalyst, it is important for it to be
unwavering in its stereochemical specificity. The results in Fig. 4.6 were first thought to be
attributed to the fact that commercially available PLE consists of a mixture of isozymes.
Separation of these isozymes and individual testing concluded that, although PLE is a
mixture, it behaves as if it were a single species.
64
,65 The inconsistency in stereoselectivity
was, therefore, attributed to the active site of PLE. This prompted research into the
development of a suitable model for the active site of PLE.
The absence of an X-ray structure for PLE prompted chemists into seeking an alternative
means to developing a model for the PLE active site. Many models have been proposed
656667 65
but the model proposed by Jones has proven to be the most successful. " Jones opted
for an empirical approach when creating a model for the active site. The model was created
in a cubic space form for various reasons. The empirical approach has been successful for
many enzymes, it is the easiest to visualise and use, and any biochemical statement
regarding the presence or absence of specific amino acids is avoided. There is also no
temptation to align the bonds of the structure along the lines of the framework of the model,
as in the case of diamond lattice models, for example.65
Jones's model is comprised of five binding loci, with the boundaries representing the
physical restrictions that amino acids of the enzyme place on the substrate (Fig. 4.7, No.
4.17 and 4.18). The catalytically essential region is the area encircling the serine (ser)
residue. It initiates hydrolysis by attack on the carbonyl group of the ester. This
nucleophilic site is best represented as a zone (l A diameter) since dissimilar substrates
orientate differently in the active site. The binding regions controlling specificity are
composed of two hydrophobic and two other more hydrophilic regions, which are
40






























HL • large hydrophobic region
HSM • small hydrophobic region
PB - back hydrophilic region
PF - front hydrophilic region
ser - serine residue
Figure 4.7: Side and top view of cubic space models of PLE active site65
The two hydrophobic regions are the large (HL) and small (HSM) regions. They interact
with the aliphatic or aromatic portions of the substrate. The HL region has a total volume of
- 56 A3, while the HSM region has a total volume of 5.5 A
3.66 There is also a "gate" at the
entrance to the HL region, which incorporates some restrictions on the steric disposition of
groups near the ester functionality.67 Double bonds and small rings near the ester can be
expected to slow the rate of hydrolysis and may lead to regioselective transformations.
There is preferential binding of the hydrophobic portion of the substrate to the HSM region.
If the moiety is too large then binding will take place in the HL region. This is the basis of
size-induced reversals of the enzyme's stereoselectivity and explains the results in Fig.
41
4.6.64 Both HL and HSM regions exclude polar groups such as hydroxyl, amino, carbonyl
and nitro functional groups. They can, however, accommodate less polar heteroatom
functional groups, such as halogen, ether or ketal oxygen atoms.
6S
The other two specified regions are more polar (P) or hydrophilic. These areas are
designated Ps (B - back of active site) and PF (F - front of active site), respectively. The PF
site binds the second, non-hydrolysed ester functionality in the case of diester substrates. It
can also accommodate non-polar groups. The Ps site interacts well with hydrogen bond
donors. A variety of alcohol, ether and carbonyl functional groups can also comfortably
locate here. The Ps site is, however, too polar to accept hydrophobic moieties. The rear
boundary of Ps as well as the space above the model is open, allowing groups to extend
b d h . "f 6Seyon t e actIve SIte 1 necessary.
Computational chemistry·, using Gaussian 98
68
and a 3-21+G basis set was utilised to
calculate the volume of the trishomocubane skeleton. This was performed to assess the
steric constraints of the cage and predict the success and applicability of PLE to the tris-a-
amino acid ester (NC5). The volume of trishomocubane was calculated to be 351.97 A3.
This volume is supposedly far too great to fit in either the HL or HSM binding region of
PLE. Although poor results were expected, PLE was still tested on NC5 since some
enzyme studies on cage systems have achieved success. For example, horse liver alcohol
dehydrogenase was successful in catalysing the reduction of pentacyclo-
[5.4.0.02,6.03,10.05,9]undecane-8,II-dione, which yielded (-)-ll-hydroxy-pentacyclo-
2,6 3,10 5,9 69[5.4.0.0 .0 .0 ]undecan-8-one.
The PLE enzyme was applied to NC5 to test the efficiency of ester hydrolysis. PLE was
added to a stirred solution of NC5 in 0.05 M KH2P04 buffer at pH 8 and 28°C.
Researchers have determined that the above mentioned conditions are required for optimum
activity of PLE.
63
,70 Figure 4.8 and Figure 4.9 shows the effect of varying pH and














Figure 4.8: Effect of pH on activity of PLE70













Figure 4.9: Effect of temperature on activity of PLE70
The reaction was run over a two-week period due to a few unanticipated difficulties. The
poor solubility of NC5 in the buffer solution and the possible steric problems induced by
the bulky cage forced a longer reaction time. After two weeks the reaction mixture was
filtered through a sintered glass funnel to remove the enzyme, followed by washing with
buffer solution. The aqueous filtrate was extracted with ethyl acetate to remove any
unreacted starting material. Unreacted ester was recovered from the organic layer, which
was evidence of a very slow reaction possibly amplified by poor solubility. The aqueous
layer was acidified to pH 6.5 by adding concentrated hydrochloric acid. This solution was
placed on a hot plate to reduce the volume, which resulted in the tris-amino acid
precipitating out of solution. The tris-amino acid was isolated by filtering off the aqueous
layer and was subsequently washed with acetone and diethyl ether. A 10 % yield of tris-
amino acid was obtained, indicating that PLE is a highly unfavourable enzyme for
hydrolysing cage related esters. The Fmoc derivative of tris-amino acid was synthesised to
obtain NMR data and confirm the presence of the trishomocubane cage. The NMR data
was identical to authentic data.
23
The application of a chiral shift reagent (Europium tris[3-
(heptafluoropropyl-hydroxymethylene)-(+)-camphorate] did not induce any splitting in the
IH or l3C NMR spectra (the spectra were identical to Spectra 34 and 35) which was a clear
indication that enantiomerically pure Fmoc-tris-amino acid was present. This was evidence
that PLE had successfully produced enantiomerically pure tris-amino acid. Unfortunately,
the low yields only afforded enough material to produce NMR data. Future investigations
should attempt to record the optical rotation of the product.
The poor yields (10 %) from the enzyme reaction did not warrant any further investigation.
The results confirm the private communication with Marchand61 stating the poor success
rate of various enzymes on cage-related compounds. It is, however, worth investigating the




Govender23 has reported the synthesis of a dipeptide consisting of glycine and tris-amino
acid. He, however, failed to extend the dipeptide or isolate a pure sample for structural
elucidation by NMR techniques. Research was, therefore, undertaken to incorporate tris-
amino acid into a longer peptide as well as isolate a pure sample for NMR analysis.
h h · f 1" d 71 72 73 d h" " hT e synt eSlS 0 non-natura ammo aCI s " an t elr mcorporatIOn mto s ort
peptides8,10,74 has been the focus of many research groups due to their various biological
applications. Incorporating cage structures into short peptides for pharmaceutical use has
b . d ' , f+ 8,9,10,11 h' d I' h'l" feen proven to m uce some posltlve elects, suc as Improve IpOp I IClty or
transport across cellular membranes. The bulkiness of the cage has also been shown to
retard metabolic degradation.
Adamantane (Fig. 5.1, No. 5.1) is one particular non-natural cage, which has exhibited
some successful biological activity.8,10 Various adamantanine peptides have proved stable
in in vivo experiments (Fig. 5.1, No. 5.2).8 This has been attributed to the steric hindrance
of the peptide bonds involved, inhibiting enzymatic degradation. This type of system may
be applicable to active substances which encounter bioavailability or transport problems.8
Various adamantyl peptides have also been proven to enhance lipophilicity and penetration
through the blood brain barrier
10
as well as significant antiviral activity.75 These results
have prompted research into incorporating cage compounds such as tris-amino acid23 (Fig.
5.1, No. 2.13) and peD amino acid
76









Figure 5.1: Biologically important cage structures
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An attempt was made to incorporate the racemic a,a-disubstituted tris-amino acid (Fig.
5.1, No. 2.13, synthesis is described in detail in Chapter 2) into a tripeptide of ala-gly-tris
(Fig. 5.2, No. 5.4) via solid phase techniques. Cu,u-disubstituted-a-amino acids display a
propensity to induce secondary folding to short peptides,77 which may be an interesting
investigation following the successful synthesis of the tripeptide.
o H 0 H 0





Figure 5.2: Proposed tripeptide of ala-gly-tris
There are two reasons why glycine was chosen: (a) it serves as an achiral linker between
the racemic tris-amino acid and (S)-Ala, to minimise diastereomeric effects visible during
NMR analysis, and (b), it is the smallest amino acid, which may assist the coupling to the
very bulky tris-amino acid.
It was Emil Fischer who first prepared a peptide of 18 amino acid residues.
1
Early peptide
work relied on solution chemistry techniques. This classical method of peptide synthesis
was successful in the preparation of several active peptides,78 however, the techniques
often encountered difficulties with solubility and purification. R.B. Merrifield's method of
solid phase peptide synthesis, which was reported in 1963, revolutionised the field of
peptide chemistry.79 The attachment of amino acid residues to an insoluble polymer
proved to be an efficient method as excess reagents and by-products could easily be
removed through filtration.
The procedure for the tripeptide synthesis involved the attachment of a linker to the resin,
synthesis of a dipeptide: ala-gly by their successive attachment to the linker, followed by
the addition of the tris-acid fluoride.
The 4-methylbenzhydrylamine resin (MBHA, 0.7 mmol NH2/g, Fig. 5.3, No. 5.5) was
prepared by swelling in N,N-dimethylformamide (DMF). This was performed to increase
the surface area of free amino groups attached to the polymeric support for coupling to the
Fmoc protected linker. Coupling to the linker (P-[(R,s)-a-[I-(9H-fluoren-9-yl)methoxy-
formamido]-2,4-dimethylbenzyl]-phenoxyacetic acid (FmocAM linker, Fig. 5.3, No. 5.6)
was achieved through the addition of N,N-diisopropylcarbodiimide (DIPCDI) and 1-






Figure 5.3: MBHA resin (5.5) and FmocAM linker (5.6)
DIPCDI (Fig. 5.4, No. 5.9) is a dehydrating agent, which favours the formation of peptide
bonds (Fig. 5.4, No. 5.10) and in the process is converted to a soluble urea co-product (Fig.
5.4, No. 5.11). HOBt is an additive, which accelerates carbodiimide-mediated couplings
and suppresses racemisation of the amino acid.
so
Note that racemisation is not a problem
with the tris-amino acid due to the lack of an acidic a-hydrogen. The resulting mixture was
stirred over a 24 hour period. The excess reagents were filtered from the mixture, followed
by successive washing with DMF. A negative Kaiser test
S1
proved the successful
















Figure 5.4: Dehydrating action of DIPCDI52
The Fmoc group on the linker (Fig. 5.5, No. 5.12) was removed by the addition of 20 %
(Iv) piperidine (Fig. 5.5. No. 5.13) in DMF and subsequent stirring for two hours.23 The
resin was washed with DMF and the Fmoc removal was verified by a positive Kaiser test.
46
The resin was washed with 1 % Cly) TFA in DMF before addition of the Fmoc-alanine to









RNH2 + CO2 +
5.17 5.16
5.15
Figure 5.5: Fmoc deprotection using piperidine38
The attachment procedure for the first and second amino acids (Fmoc-ala and Fmoc-gly)
also required the addition of DIPCDI and HOBt in DMF. The cleavage procedure for
removal of the Fmoc group again required addition of a 20 % Cly) piperidine in DMF
solution.
NMR data (Spectrum 81) was useful in verifying the successful synthesis of the dipeptide
(ala-gly). HPLC (Chromatogram 82) was used to determine the purity of the products.
The presence of one peak at 12.70 minutes in the chromatogram was proof of a pure
dipeptide. At this stage, addition of the tris-acid fluoride to the dipeptide was possible.
Previous attempts to couple the tris-arnino acid failed and partial success was achieved by
activating the acid to the acid fluoride using cyanuric fluoride. 23
It was first essential to synthesise the acid halide derivative of tris-amino acid before
coupling to the dipeptide. This was to ensure successful coupling of the sterically hindered
a,a-disubstituted tris-amino acid.82,83 There has been much success with the use of amino
acid chlorides,84,85 yet there have also been some disadvantages. N-protected amino acid
chlorides are often very highly reactive and sensitive to hydrolysis. They, therefore, need
to be used immediately after preparation and often in large excesses.86 There has also been
difficulty in preparing stable Fmoc-amino acid chlorides from trifunctional amino acids.87
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There has, therefore, been much attention paid to acid fluorides due to their high reactivity
in coupling, partly due to the small size of the fluoride leaving group.8S The acid fluorides
also display numerous advantages over the analogous chlorides. They have proven to be
more stable, often storable for up to six months under normal conditions. Oxazolone
formation in the presence of a tertiary base is not observed and has often exhibited coupling
in the absence of base.88 It has also been proven, due to the nature of the C-F bond, that
acid fluorides possess a greater stability towards neutral oxygen nucleophiles such as water
and methanol but equal reactivity to anionic nucleophiles and amines.
87
Acid fluorides are
effective in the coupling of a,a-dialkyl substituents and highly sterically hindered units
such as alamethicin acid (eight aminoisobutyric acid (Aib) and two proline residues).82
It was, therefore, decided to synthesise the Fmoc-tris-amino acid fluoride by mixing Fmoc-
tris-amino acid, dry pyridine and cyanuric fluoride in dry dichloromethane for four hours at
room temperature. This was followed by the addition of ice water. The precipitated
cyanuric acid was filtered off. Removal of the organic phase resulted in pure Fmoc-tris-
amino acid fluoride (Spectra 77_80).89
The Fmoc-tris-amino acid fluoride was added to the dipeptide along with DMF and
pyridine as a fluoride ion scavenger. This was necessary since hydrofluoric acid is
effective in cleaving MBHA linkages.
90
The resulting solution was left to stir for 24 hours.
The successful addition was confirmed by a negative Kaiser test. The Fmoc group was
removed by addition of 20 % C!v) piperidine in DMF. Confirmation of Fmoc removal was
very difficult since it was impossible to achieve a positive Kaiser test. It was speculated
that the base had failed to remove the Fmoc group and so a 30 % (Iv) piperidine in DMF
solution was applied and left overnight. A negative Kaiser test was still obtained. The
peptide was, therefore, cleaved from the resin and linker to perform NMR analysis.
The tripeptide was prepared for cleavage by washing successively with dichloromethane,
methanol and diethyl ether, followed by drying in vacuo. The cleavage mixture of 95 %
C!v) trifluoroacetic acid, 2.5 % (Iv) water and 2.5 % (Iv) triisopropylsilane was
subsequently added. The resin was removed by filtration, while the application of nitrogen
gas to the filtrate removed most of the TFA. Diethyl ether was subsequently added to
precipitate the peptide from solution. Decanting the diethyl ether served to remove the
linker from the peptide.
23
,91 NMR analysis (Spectrum 83) of the peptide confirmed the
removal of the Fmoc protecting group. The fact that a negative Kasier test was obtained
may be due to the formation of a reversible Schiff base bond (Fig. 5.6, No. 5.19), where the
free amine of the cage attacks the carbonyl functionality of the glycine residue. This is a
reasonable explanation since the absence of steric hindrance from the glycine residue in the
second position enables the peptide to fold back on itself to form a reversible six membered
ring (Fig. 5.6). Computational studies
92
suggest that tris-amino acid possesses strong p_
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Figure 5.6: Formation of a Schiff base bond
The NMR analysis of the tripeptide also showed that it contained impurities, which was
confirmed by HPLC results (Chromatogram 84). The fact that the peptide was present as
a mixture of diastereomers [(S)-ala-gly-(R)-tris and (S)-ala-gly-(S)-tris] accounted for the
broad peak representing the tripeptide (31.22-39.72 minutes), which exhibited identical
ultraviolet spectra (Chromatogram 84). This broad peak could not be resolved. Mass
spectrometry (Spectrum 85) was useful in confirming the synthesis of the tripeptide by the
presence of the molecular ion peak at rn/z 334 [M+Ht. A summary of the peptide
synthesis is depicted in Fig. 5.7.
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Figure 5.7: Summary of peptide synthesis
The tripeptide was successfully synthesised according to mass spectrometry results. The
product proved difficult to purify, and consequently a full structural elucidation by NMR
techniques was not possible. In order to prevent the back turning of the tris-amino acid and
prevent some of the problems experienced, would be to avoid glycine insertion at the i+ I





The synthetic work described in the previous chapters relied on the formation of
trishomocubane from the rearrangement of the PCU skeleton. A computational
investigation was, therefore, undertaken to gain insight into the mechanism for the
rearrangement.
6.1 Introduction
Many of the mathematical algorithms necessary for computational chemistry have been
available for many years, yet the discipline has only recently become accessible to the
average chemist with the improvement of computer hardware and software. Computational
chemistry is, therefore, a fairly new discipline and has become a useful tool to chemists,
enabling a more comprehensive understanding of chemical reactions and processes. It has
allowed chemists to predict the stability of chemical reactions, to estimate energy
differences between different states and to explain reaction mechanisms.
93
This
information is invaluable, particularly in research, where laboratory-based experiments are
expensive and time-consuming.
Computational chemistry simulates chemical structures and reactions numerically and is
based on the fundamental laws of physics.
94
There are two categories within computational
chemistry: molecular mechanics and electronic structure theory.
Ab initio methods, a class within electronic structure theory, perform calculations based on
the fundamental laws of quantum mechanics and on the values of a few physical constants:
the speed of light, the masses and charges of electrons and nuclei, and Planck's constant.94
Ab initio methods are derived directly from theoretical principles with no inclusion of
experimental data.
Ab initio methods were used to examine the rearrangement mechanism of the PCU-diol to
7-fluoro-ll-hydroxy-trishomocubane via two proposed mechanisms. Before the discussion
of the two proposed mechanisms, a short overview on computational chemistry will be
presented.
Ab initio methods compute solutions to the Schrodinger equation (Eq. 6.1) by using a series
of rigorous mathematical approximations and provide high quality quantitative predictions
for a broad range of atomic and molecular systems.94 The Schrodinger equation is
represented as:
(6.1)
where H is the Hamiltonian operator. This is represented as:
h 2 nu 1 2 h 2 elec 2 2 nu elec Z A 2 flU nu Z AZ B
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(6.2)
where M are the nuclear masses, a are electrons, A are nuclei, RAB are the distances
separating nuclei, fab are the distances separating electrons and fAa are the distances
separating electrons and nuclei. The first two terms represent the kinetic energy of the
nuclei and the electrons, while the last three terms represent the Coulombic interactions
between particles.
The Shrodinger equation is a combination of the differential equation describing the profile
of a simple harmonic standing wave and de Broglie's relation between matter and waves.
16
Manipulations of this equation allow the description of molecules in terms of interactions
among nuclei and electrons, and molecular geometry in terms of minimum energy
arrangements of nuclei.
95
Unfortunately, this many electron equation cannot be solved
exactly for systems that involve three or more interacting particles, therefore, some
approximations need to be introduced.
96
These will be briefly described in sections 6.1.1-
6.1.4.
6.1.1 Born-Oppenheimer Approximation
In this method it is assumed that the nuclei of a system do not move.95 The mass of a
nucleus is thousands of times greater than that of an electron, therefore, nuclei move slowly
with respect to electrons and electrons respond instantaneously to changes in nuclear
positions.
16
Consequently, the energy of a molecule in its ground state can be considered a
function of the nuclear co-ordinates only. The electronic wavefunction thus depends only
on the positions of the nuclei and not on their momenta.
16
This approximation leads to the
"electronic" Shrodinger equation (Eq. 6.3), where the nuclear kinetic energy is excluded
and the nuclear-nuclear Coulomb term is constant.
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This approximation involves the replacement of the many electron wavefunction by a
product of one-electron wavefunctions, termed spin orbitals. Each spin orbital is written as
a product of a space part, fj/, and is termed a molecular orbital with one of two possible spin
parts, a or fJ. Only two electrons may occupy a given molecular orbital and must be of
. . 16
OpposIte spm.
The Hartree-Fock level of theory is the entry level of ab initio techniques. There are better
levels of theory such as DFT, MP2, MP4, etc., but they are very expensive with regard to
hardware resources and time.
6.1.3 LeAD Approximation
Molecular orbitals are expressed as linear combinations of a finite set (a basis set) of
predescribed functions: known as basis functions, f/J (Eq. 6.6):
bs
lfIi = ICJJif/JJJ (6.6)
JJ
where cjJi is the molecular orbital coefficient (often incorrectly referred to as molecular
orbitals), f/JJ.l are the atomic orbitals because they are usually centred at the nuclear position
and bs are the basis functions.
Hartree-Fock theory takes advantage of the variational principle to solve for the set of
molecular orbital expansion co-efficients by finding the set of co-efficients that minimise
the energy of the resultant wavefunction.94
6.1.4 Roothaan-Hall Equations95
The application of Hartree-Fock and LeAD approximations to the electronic Shrodinger




where £i are the orbital energies, S is the overlap matrix (extent to which basis functions
"see each other") and F is the Fock matrix (average effects of the field of all the electrons
on each orbital), which is represented in atomic units as:
/ 1 nu Z ) bS bS [ 1 Il
FJJv =\f/JJJ -2V2 - ~ r; If/Jv +~~PM (f/JJJf/Jvlf/J,tf/JJ- 2 (f/JJJf/J,tIf/Jvf/JJJ
The first term represents the kinetic energy and potential energy of individual electrons, the
second term represents the interactions among electrons, P is the density matrix (energy of
a single electron in the field of the bare nuclei) and PM is represented as:
DeeM.D.s
PM = 2 L>~eoi
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(6.9)
where oeeM.o.s are the occupied molecular orbitals.
The solutions of the Roothaan-Hall equations are termed ab initio models. These models
treat the motions of individual electrons as independent of one another. This leads to an
overestimation of the electron-electron repulsion energy. This results in an overestimation
of the total energy since electrons "get in each others way" to a greater extent than they
should. The problem is solved by the self-consistent field (SCF) approximation. Through
SCF any instantaneous electron-electron repulsions are neglected. Each electron is
considered to interact with the average field generated by the global charge distribution of
all the other electrons in the system, rather than with other electrons taken as distinct
particles. An adjustment in one orbital changes the SCF effective potential and may lead to
an adjustment in the form of another orbital, and so on.
94
One of the problems of using
molecular orbital theory with the SCF approximation is how to treat molecules with and
without unpaired electrons: closed or open shell systems. Restricted Hartree-Fock (RHF)
or closed shell calculations force each electron pair into a single spatial orbital (Fig 6.1, a),
while Unrestricted Hartree-Fock (UHF) or open shell systems use separate spatial orbitals
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Figure 6.1: Restricted Hartree-Fock versus Unrestricted Hartree-Fock
With UHF, the two sets of orbitals are similar but not necessarily identical. By convention,
any unpaired electrons are designated alpha spin.16 UHF is more flexible than RHF
because the formally paired alpha and beta orbitals, which correspond to double occupied
molecular orbitals in RHF, need not be identical, and can be independently adjusted to
achieve a lower energy.16 UHF is generally a much more time consuming tool, but is the
most appropriate way to deal with molecules near the dissociation limit.96
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6.2 Basis Sets for ab initio and DFT Calculations
A basis set is a mathematical description of the orbitals within the system used to perform
the theoretical calculations.
94
The number of atomic orbitals determines the quality of the
molecular orbital. If there are many electrons in a molecule then the number of atomic
integrals required increases rapidly.16 The Gaussian 98
68
program offers a range of pre-
defined basis sets, classified by the number of types of functions they contain.16 Minimal
basis sets are characterised by fixed size atomic orbitals, and contain the minimum number
of basis functions needed for each atom,94 for example, hydrogen only contains an Is
orbital, while carbon is allowed Is, 2s, 2px, 2py and 2pz orbitals.
Minimal basis sets are well known to have several deficiencies. Atoms such as oxygen and
fluorine are described using the same number of basis functions as the atoms at the
beginning of the period, despite the fact that they have more electrons. The functions
cannot expand or contract in size in accordance with the molecular environment. They
cannot describe non-spherical aspects of the electron distribution.96
Split-valence basis sets increase the number of basis functions per atom and introduce two
or more sizes of basis functions for each valence orbital, for example, hydrogen is allowed
an Is andls' orbital, and carbon an Is, 2s, 2s" 2px, 2py, 2pz, 2px', 2py', 2pz· orbital. The
primed and unprimed orbitals differ in size but not in shape.95
Split-valence basis sets allow for the fact that the p-orbitals, which make up a "tight" (j
bond, need to be more contracted than the p-orbitals, which make up a "looser" 7[ bond
(Fig. 6.2).95
Pa = aCx:J + j3 D<J :> Cx:J a
g g :> gPJr= a + j3 b
Figure 6.2: Example of orbitals used in a split-valence set
6.2.1 Split-Valence Basis Set Incorporating Diffuse Functions (3-21+G)
This basis set represents inner shell atomic orbitals by a single set of functions, which, in
turn, is written in terms of three Gaussians. Basis functions representing inner and outer
components of valence atomic orbitals are written in terms of expansions of two and one
Gaussians respectively.95 Heavy atoms are provided with diffuse functions (which is
designated by the "+" sign). Diffuse functions are large size versions of sand p-type
functions, and allow orbitals to occupy a larger region of space. This is important for
systems where electrons are relatively far from the nucleus, molecules with lone pairs,
anions, systems in excited states and systems with low ionisation potentials.94
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6.2.2 Polarisation Basis Set Incorporating Diffuse Functions [6-31+G(d)]
This basis set represents inner shell atomic orbitals by a single set of functions, written in
terms of six Gaussians. The inner and outer components of the valence atomic orbitals are
written in terms of three and one Gaussians respectively. Diffuse functions as well as a set
of six d-type polarisation functions are included for each heavy (non-hydrogen) atom.
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Ab initio methods offer the advantage that they may eventually converge to the exact
solution once all approximations become sufficiently small. They are also dis-
advantageous: they are often expensive regarding CPU time, memory and disk space. In
general they are an excellent qualitative tool, becoming more quantitative for smaller
molecules. As hardware and software develop, ever increasing molecular sizes will be
studied with improved accuracy.
6.3 Other Models
6.3.1 Semi-Empirical Methods
Semi-empirical methods follow directly from Hartree-Fock methods. Semi-empirical
methods introduce various approximations, which reduce the computational effort
characteristic of ab initio methods. They may also incorporate parameters derived from
experimental data or high level ab initio calculations to simplify the computation.
Semi-empirical methods only consider the valence electrons of the system and considers
inner shell electrons to be part of the nuclear core.93,94,95 This is rationalised by the fact
that the electrons involved in chemical bonding are those in the valence shell. The second
approximation is that the basis set is restricted to a minimal representation. For main group
elements, this comprises a single s-type function and a set of p-type functions, for example,
2s, 2px, 2py, 2pz.
For transition metals, a set of d-type functions, a s-type function and a set of p-type
functions are included, for example, 3d/-/, 3dz2, 3dxy, 3dxz, 3dyz, 4s, 4px, 4py, 4pz.
A feature common to semi-empirical methods is that some of the elements that correspond
to the overlap between two atomic orbitals on different atoms are set to zero. This serves to
simplify the Roothaan-Hall equations. It is, however, important to include some of the
overlaps in even the simplest semi-empirical models.
With the exception of modelling transition states, semi-empirical methods can reproduce a
variety of experimental data, such as heats of formation, dipole moments and ionisation
potentials.
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Accuracy is, however, limited, largely because the models are parameterised,
often upon the results from relatively low-level ab initio calculations.94 In general, semi-
empirical methods are faster than ab initio methods, yet results can be erratic if the
molecule is significantly different from the parameterisation set.
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6.3.2 Molecular Mechanics
Many molecular modelling systems are too large to be considered by quantum mechanical
methods. Quantum mechanics deals with electrons within a system and, even if some are
ignored (semi-empirical), a large number of particles must still be considered. Molecular
mechanics (empirical force field calculations) ignore electronic motions and calculate the
energy of a system as a function of the nuclear positions only.94 Different molecular
mechanics methods are each characterised by a particular force field. A force field
comprises a set of equations defining how the potential energy of a molecule varies with
the locations of its component atoms. Molecular mechanics force fields describe molecules
in terms of "connected atoms", and molecular geometry in terms of distortions from "ideal"
bond distances, bond angles and dihedral angles, together with an account of non-bonded
van der Waals and Coulombic interactions (Eq. 6.1.9, also see Fig. 6.3).93 The total energy
is given by:
bonds bond angles dihedral angles nonbonded atoms
E IOWI = I Ettretch + I E1end + I E:ors;on + I I E;onbonded
i j
(6.10)
The first three summations are over all bonds, all bond angles and all dihedral angles











non-bonded interactions (van der Waals)
d
Figure 6.3: Schematic representation of the five key contributions to a
molecular force field
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Molecular dynamic methods can produce very accurate results with respect to geometry
and energies of very large systems, at a fraction of the time compared to ab initio methods.
The method, however, can be prone to huge error if the force field is not specifically
designed for a specific system. The method is also not applicable to transition state
calculations.
6.3.3 Density Functional Theory
Density functional theory (DFf) methods are very similar to ab initio methods, in that they
require similar resources but are not as expensive. Electrons in a molecular system react to
one another's motion and attempt to 'keep out of each others way'. DFf accounts for the
effect of electron correlation and is, therefore, a more attractive method than ab initio. DFf
is based on the theory that the ground state energy of any molecule can be described in
terms of the electron density, that is, each molecule has a unique functional which exactly
determines its geometry. This system differs to the wave function approach of ab initio
methods, where the complexity of the wave function increases by a factor of 3N for an N
electron system. The complexity of the DFf function is less dependant on the system size
since electron density has the same number of variables. The advantage of DFf methods is
that only total electron density needs to be considered.
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The accuracy of results from DFf calculations vary from poor to fairly good, depending on
the choice of basis set and density functional. DFf tends to give energy values that are
lower than the expected energy, whereas ab initio methods asymptotically approach the
expected energy as the basis set is improved. DFf has been improved with the use of
hybrid functionals such as B3LYF. B3LYP with a 6-31G(d) basis set is the most widely
used due to the accurate results obtained for organic molecules
98
and was used to optimise
tris-hydantoin in Chapter 2.
6.4 Transition State Modelling
The 3-21+G basis set is the minimum basis set for ab initio calculations that still provides a
reasonable answer for transition state geometries and energies. It is relatively inexpensive
in terms of CPU time and is a logical choice when one is still in a learning phase.
Upgrading of results to a better level of theory and basis set is trivial after one has
determined all possible reaction details.
A transition state is a molecular species that is represented by the maximum on a potential
energy curve in a simple one-dimensional reaction co-ordinate diagram. It is difficult to
predict the geometry of a transition state without the aid of computational chemistry, yet,
experimentally it has recently become possible by femtosecond pulsed laser spectroscopy.99
Unfortunately, this method is currently only available to a limited number of very specific
systems and we still have to rely largely on computational methods to gain insight into the
mechanistic detail of most reactions.
In order to determine a transition state computationally, a modelling program could be used
to perform a linear step search for the lowest maximum on the energy surface between
reactant and product. This is achieved by performing a SCAN calculation (Gaussian 98),
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where the transition state is found at the top of the potential curve. A SCAN job can be
performed if one knows which bond will break or form during the reaction. SCAN jobs
typically increase/decrease a bond length (angle or dihedral angle) in a stepwise manner.
At each step the molecule is optimised while only constraining the specified SCAN
parameter. A frequency calculation is performed on this structure to verify it as the correct
transition state. A frequency calculation determines the number of imaginary frequencies
and the normal modes corresponding to the imaginary frequencies. Imaginary frequencies
are stored in the output file as negative eigenvalues. A structure which has n imaginary
frequencies is an nth order saddle point. A transition state is usually characterised by one
imaginary frequency since it is a first order saddle point. The movement of atoms
associated with the imaginary frequency should follow the atoms on the reaction co-
ordinate between reactant and product.
A less mechanical approach to finding a transition state involves guessing a transition state
starting structure and then performing a full, unrestricted transition state optimisation. The
output file of the calculation is closely followed to detect any changes that may need to be
made to the reaction co-ordinates. This method can be complicated by using constrained
reaction co-ordinates, while the rest of the structure is optimised using a transition state
optimisation algorithm. This approach is able to find a better starting structure for a full,
unconstrained transition state optimisation, yet requires experience and a good knowledge
of transition state reaction co-ordinates for a specific system.
6.5 Computational Tools
6.5.1 Gaussian 98 Program 68
This is a program capable of performing ab initio Hartree-Fock molecular orbital
calculations, dealing mainly with Gaussian-type orbitals based on a LCAO approach. It is
capable of computing energies, molecular structures and vibrational frequencies in the gas
phase or in solution. The input section of the program requires the molecular charge,
multiplicity, the symbols of the constituent atoms and a definition of the molecular
structure in terms of Cartesian co-ordinates. This information must be accompanied by an
appropriate instruction with regard to basis set and level of theory. All calculations
reported here were performed with the Gaussian 98 program (G98).
6.5.2 Gauss View
This is a Graphical User Interface (GUI), used in conjunction with G98. It is used to build
molecules that are to be submitted to G98 as well as view results from G98. Its animation
abilities allow transition states to be viewed that are associated with the negative
eigenvalues of the transition state.
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6.6 Results for PCU Rearrangement to Trishomocubane
Ab initio (RHF) methods using a 3-21 +0 basis set were employed to determine the starting
structures, transition states and products for the two proposed mechanisms: Proposed
Mechanism 1 (Fig. 6.4) and Proposed Mechanism 2 (Fig. 6.5) of the PCD-diol (Fig. 6.4,
No. 6.1 and Fig. 6.5, No. 6.5) to the f1uorotrishomocubyl alcohol (Fig. 6.4, No. 6.4 and Fig.
6.5, No. 6.10). The synthesis
26
requires refluxing the diol in hydriodic acid (HI) at 100 QC
for two hours to yield the iodotrishomocubyl alcohol. In order to simplify the
computational simulation for the assigned basis set, it was decided to employ hydrofluoric
acid (HF) instead of HI for the PCD diol rearrangement. The synthetic procedure utilised
in Chapter 2 made use of the PCD mono alcohol and acetic acid.43 A similar mechanism
for rearrangement should hold for this system as that described in this chapter for the PCD-
diol.
The Proposed Mechanism 1 (Fig. 6.4) for the rearrangement of the PCD-diol to
trishomocubane involved the protonation of Os on the hydroxyl group of 8-exo-hydroxy-
II-exo-hydroxy PCD. This transition state was omitted from the results since it yielded
unrealistic energy values. This was due to the fact that it is a charged molecule and the
calculation is performed under gas phase conditions. The transition state (Fig. 6.4, No. 6.3)
that followed, involved the breaking of the C I,7 PCD bond, the formation of the Cl,S bond to
induce cage rearrangement through an intramolecular SN2 mechanism, and attachment of a
fluorine atom to the C7 exo position to yield 7-exo-f1uoro-ll-exo-hydroxy-trishomocubane.
This exact procedure was followed for 8-exo-hydroxy-II-endo-hydroxy PCD to yield 7-
exo-f1uoro-ll-endo-hydroxy-trishomocubane (Fig. 6.4). Note that the chemical procedure
yields a racemate. Since enantiomers have the same geometry* in space, as well as
identical energies, only one enantiomer was chosen for the computational model. All
reported transition states are available on CD attached at the back of this dissertation
(Appendix 4).























Figure 6.4: Proposed Mechanism 1
The Proposed Mechanism 2 (Fig. 6.5) involved the addition of fluorine through the SN2
displacement of the protonated form of the alcohol at C8 (Fig. 6.5, No. 6.7). This was
followed by cage rearrangement as described in Proposed Mechanism 1 to yield the



















, --:. H shift,












Figure 6.5: Proposed Mechanism 2
The project began by first attempting to find the transition state of the protonated form of
trishomocubanol (Fig. 6.6, No. 6.11) to get a feel for the mechanism. This was achieved by
performing a SCAN calculation: scanning the Cl and Cs carbon atoms closer together, since
these are the atoms involved in cage rearrangement. A simple plot of energy from each
SCANNED step versus the corresponding bond distance revealed a maximum where the Cl
and Cs atoms were 1.92 A apart. The co-ordinates for this structure were saved as an input
file for an unconstrained transition state optimisation, followed by a frequency calculation.
One negative eigenvalue was obtained and the movement of atoms associated with the
negative eigenvalue was evidence of cage rearrangement. These cage co-ordinates
provided the skeleton upon which the remaining transition state calculations were
performed. Many of the transition states that were subsequently calculated proved to






Figure 6.6: Transition state for the protonated trishomocubanol
The transition states for Proposed Mechanism 1 were achieved by adding the relevant
functional groups in the relevant stereochemistry to the input structure of 6.11, optimising
the structure, and lastly, scanning the fluorine atom towards C7 until a maximum on the
potential energy curve was obtained. The structure was subsequently used as an input file
and a frequency calculation performed in order to verify the structure as a transition state.
The transition state structures for the exo-endo protonated diol (Fig. 6.7. No. 6.12) and exo-
exo protonated diol (Fig. 6.8, No. 6.13) are shown in Fig. 6.7 and Fig. 6.8. It is clear from
Fig. 6.7 and Fig. 6.8 that the stereochemistry of the hydroxy group attached to C II has very
little influence on the geometry of the transition states.
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6.12
Figure 6.7: Transition state for the exo-endo PCU diol
6.13
Figure 6.8: Transition state for the exo-exo PCU diol
A simple one-dimensional plot of relative energy versus reaction pathway (Fig. 6.9) of the
two relative pathways revealed a very small difference in transition state energies. The
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exo-endo PCD diol proved to be a slightly better starting material for rearrangement as it's
transition state proved to be 2.6 kcal mor' lower than the exo-exo diol analogue (Fig. 6.9).
Since the reaction is performed under reflux conditions, using aqueous HI,43 the difference
of 2.6 kcal mort in activation energy would probably not prevent both isomers (6.12 and
6.13) from simultaneously forming. Molecules have enough thermal and kinetic energy at
room temperature to allow processes requiring 15 to 20 kcal mor 1.100
H F
6.146.15











Figure 6.9: Reaction pathway for Proposed Mechanism 1
As far as Proposed Mechanism 2 is concerned, it proved very difficult to find the
transition state for the SN2 displacement of water by a fluorine ion (Fig. 6.5, No. 6.7). Note
that fluorine was chosen to minimise the computational model with respect to time and
resources, as mentioned before. Even a SCAN job failed to isolate the optimum structure
for transition state analysis. To overcome this problem with fluorine, the SN2 displacement
of water by a bromine ion was modelled and easily found. Bromine was therefore, used to
calculate the energy of the first transition states (Fig. 6.10, a and b). This would at least



























e=exoF-exoOH + HF + H20
f=exoF-endoOH +HF + H20
g=7-exo-fluoro-11- endo-hydroxy-trishomocubane
h=7-exo-fluoro-11-exo-hydroxy-trishomocubane
Figure 6.10: Reaction pathway for Proposed Mechanism 2
The transition states for cage rearrangement of the two isomers (Fig. 6.11 and Fig. 6.12)
were subsequently calculated by performing frequency calculations on the optimised cage
structures of the two isomers of 8-fluoro-ll-hydroxy-trishomocubane, hydrofluoric acid
and water. The movement of atoms associated with the corresponding negative
eigenvalues confirmed cage rearrangement. As the C I,8 bond formed there was migration
of the FI atom to C7 and Hx to the Ob atom. This was accompanied by migration of the F2
atom to the Hy atom of the water molecule to ultimately yield 7-hydroxy-ll-fluoro-





Figure 6.11: Transition state for 8-exo-fluoro-11-exo-hydroxy-PCU
-8y
6.17
Figure 6.12: Transition state for 8-exo-fluoro-11-endo-hydroxy-PCU
It is again clear from Fig. 6.11 and Fig. 6.12 that the stereochemistry of the hydroxy group
attached to C ll has very little influence on the geometry of the transition state. A one-
dimensional plot of relative energy versus reaction pathway (Fig. 6.10) of the two relative
pathways revealed a very small difference in transition state energies. The exo-exo
analogue (Fig. 6.11, No. 6.16) proved to be a slightly better starting material for
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rearrangement as it's transition state proved to be 0.2 kcal mor' lower than the exo-endo
analogue (Fig. 6.12, No. 6.17).
The rate-determining step in Proposed Mechanism 2 involves the SN2 displacement of the
protonated endo-hydroxy group by the halogen in the exo orientation. The rest of the
process is downhill. --~-
This computational investigation revealed that the stereochemistry of the hydroxyl group at
the C ll position has little effect on the transition state energy during cage rearrangement. It
was also evident from the movement of atoms associated with the transition states that the




This project had four aims: (a) to improve the synthesis of racemic 4-amino-(D3)-
trishomocubane-4-carboxylic acid (tris-amino acid), (b) to synthesise enantiopure tris-
amino acid, (c) to incorporate racemic tris-amino acid into a short peptide, and (d) to
perform a computational investigation on the rearrangement of the peD skeleton to
trishomocubane.
Two novel derivatives of tris-hydantoin (NCl and NC2) were synthesised during an
investigation that was aimed at improving the yields of tris-amino acid. The base (LiOR)
hydrolysis of NC2 quantitatively yielded tris-amino acid. This was a significant
improvement on previous methods, which required base (NaOR) hydrolysis of tris-
hydantoin (60 % yield).
Two novel tris-hydantoin derivatives (NC3 and NC4) were also synthesised in an attempt
to produce separable diastereomers. The investigation was aimed at separating the
diastereomers, followed by base hydrolysis of the hydantoin ring to yield enantiopure tris-
amino acid. The diastereomers, however, were inseparable by column chromatography, so
this particular route to produce enantiopure tris-amino acid was abandoned.
A novel ester derivative of tris-amino acid (NC5) was synthesised in an attempt to produce
enantiopure tris-amino acid by the application of PLE enzyme. The poor solubility of NC5
in the buffer solution and the bulky nature of the cage may have been the reason for the low
yield (l0 %) of enantiopure tris-amino acid. Due to the low yield, only NMR analysis was
possible. The application of a chiral shift reagent to the tris-amino acid during NMR
analysis did not result in any splitting of the NMR peaks. This was a clear indication that
enantiopure tris-amino acid was present. Future investigation should attempt to record the
optical rotation of the enantiopure tris-amino acid. Alternative enzymes, such as
hydantoinase should also be considered for future enzyme work on trishomocubane
derivatives.
Previous research managed to incorporate tris-amino acid into a dipeptide, consisting of
glycine and tris-amino acid, yet they failed to further extend the peptide or obtain a suitably
pure sample for two-dimensional NMR analysis. An attempt was, therefore, made to
synthesise a longer peptide and obtain a pure sample for two-dimensional analysis. A
tripeptide consisting of alanine, glycine and tris-amino acid was successfully synthesised,
yet difficulty was experienced in extending the peptide due to a possible Schiff base
interaction between the amino group of tris-amino acid and the carbonyl functionality of
glycine. A pure sample of the tripetide could not be obtained for two-dimensional NMR
analysis.
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The mechanism of the PCD rearrangement to form trishomocubane is not well understood,
therefore, a computational investigation of this was pursued. The investigation revealed
that the stereochemistry of the hydroxyl group at the Cll position of the PCD-diol had little
effect on the transition state energies of the various isomers. The movement of atoms
associated with the transition states also indicated that the rearrangement of PCD to




Melting points were recorded using a Bombay 400 013 instrument from Shital Scientific
Industries. All melting points are uncorrected. Infrared spectra were obtained using a
Nicolet Impact 410 spectrometer. The one-dimensional NMR spectra were recorded on a
Varian Gemini 300 MHz spectrometer, while the two-dimensional NMR spectra were
recorded on a Varian Unity Inova 400 MHz spectrometer. The fast atom bombardment
(FAB) mass spectra were obtained from a Micromass VG70-70E mass spectrometer,
equipped with an In tech FAB gun. The samples were bombarded with xenon atoms (1 mA
at 8 keV), with m-nitrobenzyl alcohol as the matrix. Electron impact (El) mass spectra
(70eV) were obtained from a Micromass Autospec-TOF mass spectrometer. Elemental
analyses were obtained from a Leco CHNS 932 instrument. HPLC analysis was performed
using a Waters 600 solvent delivery system, equipped with a Perkin Elmer series 700
autosampler, a Waters 996 photodiode array detector and Millenium software. A Nucleosil
100 CI8 column (5 J...lm particle size, 250 mm x 4.6mm i.d.) was also used.
Synthesis of 5,8-methano-4a,5,8,8a-tetrahydro-l,4-naphthoquinone (2.17,
adduct)37,40,101
p-Benzoquinone was dissolved in dry toluene (4.00 1) and placed in an ice/salt bath within a
dark fumehood. Cold, freshly cracked cyclopentadiene (132.00 ml, 1.96 mols) was added
over two hours via a dropping funnel. The slow addition and cool temperatures allowed a
successful Diels-Alder reaction, without polymerisation of the cyclopentadiene. The
reaction was left to stir overnight. The solution was removed from the ice/salt bath,
wrapped in tin foil and left in the dark fumehood to allow complete evaporation of the
toluene to leave yellow crystals of adduct (229.68g, 74 %). m.p. 77°C. IR (KBr) 3315
(w), 1667 (vs, C=O), 1596 (s, conjugated C=C), 1293 (m), 1280 (m), 1053cm-1 (m). IH
NMR [CDCh, 300 MHz]: bH 1.50 (m, 2H, methylene bridge protons), 3.20 (m, 2H, H4a,
H8a), 3.50 (m, 2H, bridgehead protons), 6.02 (m, 2H, ethylene bridge protons), 6.50 (s, 2H,
enone vinyl protons). 13C NMR [CDCh, 300 MHz]: be 48.35 (d), 48.72 (t), 48.78 (d),
135.30 (d), 142.06 (d), 199.45 (s). M.S. was identical to an authentic sample.
Synthesis of pentacyclo[5.4.0.02,6.03,10.Os,9]undecane-8-11-dione (2.19)37,102
The synthesised adduct was added to a volumetric flask (5.00 1) and dissolved in 10 % Clv)
acetone in hexane solution (5.00 1). The volumetric flask was exposed to direct sunlight
until a colourless solution was obtained. The solvent was evaporated in vacuo to give a
white, microcrystalline solid (183.74g, 80 %). m.p. 240 QC. IR (KBr) V max 2974, 1709 cm-
I (vs, C=O). IH NMR [CDCh, 300 MHz]: bH 1.83-2.03 (AB ~uartet, 2H, methylene bridge
protons), 2.66-3.14 (broad absorption, 8H, methine protons). I C NMR [CDCh, 300 MHz]:
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Oc 38.74 (C2, C6), 40.49 (C4), 43.79 (C3, Cs), 44.62 (C9, CID), 54.72 (Cl, C7), 212.21 (Cg,
CII). M.S. M.S. was identical to an authentic sample.
Synthesis of pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-11-dione-mono-eth-
31)4243ylene ketal (2. '
A mixture of the diketone (183.00 g, 1.05 mol), ethylene glycol (81.20 ml, 1.45 mol), p-
toluenesulfonic acid (6.11 g, 3.21xlO-2 mol) and A4 molecular sieves (2 g) in dry toluene
(800 ml) was refluxed with stirring in a Dean and Stark trap for four days. The reaction
mixture was left to cool and poured slowly into ice-cold lO % Clv) aqueous sodium
carbonate (1.00 1). This was extracted with dichloromethane (3 x 500 ml). The combined
organic extracts were dried over anhydrous sodium sulphate. The mixture was filtered and
the solvent evaporated in vacuo. The resulting brown residue was recrystallised from
hexane to give the mono-ketal as white crystals (170.04 g, 74 %). IR (KEr) Vmax 1747 cm-I
(vs, C=O). IH NMR [CDCh, 300 MHz]: OH 1.51-1.84 (2H, methylene bridge protons),
2.35-2.92 (8H, methine protons), 3.78-3.91 (4H, ketal protons). l3C NMR [CDCh, 300
MHz]: Oc 36.35 (d), 38.74 (t), 41.33-53.02 (d), 64.52-65.71 (t, ketal carbons), 113.92 (s),
215.14 (s). M.S. was identical to an authentic sample.
. 4 0 26 03 10 5 9]SyntheSIS of II-hydroxypentacyclo[5...0'. ' .0' undecane-8-one- eth-
ylene ketal (2.34)42,43,103
The mono-ketal (10.00 g, 4.59xlO-2 mol) was dissolved in ethanol (100 ml) and placed in
an ice-bath to cool. An ethanolic solution of sodium borohydride (3.50 g in 50 ml) was
added, with stirring, over a 10 minute period. The mixture was left to stir for two hours in
the ice-bath, and an additional two hours at room temperature. Some sample (5 m)) was
withdrawn to confirm complete reduction of the keto functional group. The solvent of this
sample was removed in vacuo, and the residue extracted using dichloromethane (50 ml).
The organic extracts were combined, thereafter, the solvent was removed in vacuo to leave
the hydroxy-ketal as a homogenous oil (7.70 g, 77 %). m.p. 250 QC. IR (KBr) V max 3452
(s), 2956 (s), 11l4cm-1 (s). IH NMR [CDCh, 300 MHz]: OH 1.04 (Ha, JAB 8.91 Hz), 1.54
(Hs, JAB 8.79 Hz), 2.lO-2.60 (m, 8H, methine protons), 3.49-3.91 (m, 5H, 4 protons of ketal,
OH), 5.25 [lH, t, J -5 Hz, HCI-H(exo)CwHC ID]. l3C NMR [CDCh, 300 MHz]: Oc 35.01
(t), 38.88 (d), 39.07(d), 39.27 (d), 39.91 (d), 43.62 (d), 44.65 (d), 46.77 (d), 47.24 (d), 63.00
(t), 65.54 (t), 72.36 (d), 115.82 (s). M.S. was identical to an authentic sample.
Synthesis of 11-hydroxypentacyclo[5.4.0.02,6.03,10.05,9]undecane-8-one
(2.40)43
The hydroxy-ketal was placed in an ice-bath to cool at which stage lO % Clv) hydrochloric
acid (200 ml) was cautiously added. This was left, with stirring, to warm to room
temperature for 18 hours. The mixture was extracted with dichloromethane (150 ml) to
yield the hydroxy-ketone (4.84 g, 60 %). IR (KBr) vmax 3407 (m, OH), 2975, 1738 cm- I (s,
vs, C=O). IH NMR [CDCh, 300 MHz]: OH 1.47 (l/2H, d, J4a,4s 10.56 Hz, H4a), 1.51 (1I2H,
d, J4a,4s lO.56 Hz, H4a), 1.86 (1H, d, J4a,4s 11.00 Hz, H4s), 2.37-2.97 (8H, HI, H2, H3, Hs, H6,
72
H7, H9, H IO), 4.04 (l/2H, t, J 4 Hz, Hs), 4.35, (lH, t, J 5 Hz, D20 exchangeable OH), 4.56
(lH, t, J 5 Hz, Hs). 13C NMR [CDCL3]: 36.84, 38.32, 40.79, 41.59 (2C), 41.75, 41.90,
42.47,42.76,43.94,44.15,44.25,45.00,45.12,50.02, 53.56 54.45, 54.56, 75.26, 81.40,
122.01, (O-C-O) and 218 (C=O). M.S. was identical to an authentic sample.
• 26 310 059] d 8) (2 46)3043104SynthesIs of endo-pentacyclo[5.4.0.0 ' .0' . ' un ecane- -0 . "
A mixture of the hydroxy-ketone (15.00 g, 8.52xI0-2 mol) and hydrazine hydrate (23.10 rnI,
0.74 mol) in diethylene glycol (200 rnI) was refluxed, with stirring, at 120°C for two hours.
The mixture was allowed to cool to 80°C at which stage excess KOH (12.00 g, 0.21 mol)
was added. Excess hydrazine hydrate and water was distilled from the mixture until the
temperature reached 185°C, thereafter, refluxed for a further three hours at 185°C. The
mixture was cooled, diluted with water (300 rnI) and extracted with dichloromethane
(3x 100 rnI). The combined organic phases were removed in vacuo. The yellow residue
was distilled by steam distillation to yield the alcohol as a colourless oil with a camphor-
like odour (8.02 g, 58.10 %). m.p. 231°C. IR (KBr) Vmax 3403 (m, OH), 2952 cm-I. IH
NMR [CDCh, 300 MHz]: ()H 1.05 (1H, dd, J 4Hz, Hllx), 1.14 and 1.67 (2H, AB system,
J4a4s 10 Hz, H4a, H4s), 1.58 (1H, s, D20 exchangeable OH), 2.26 (1H, d, Jlln.llx 12 Hz, H11n,
obscured by env.), 2.18-2.73 (8H, env., HI, H2, H3, Hs, H6, H7, H9, H IO) and 3.91 (1H, m,
Hs). 13C NMR [CDCh]: ()e 28.78 (C lI ), 35.16 (C4), 35.92 (Cl), 38.82 (C7), 39.91 (C6),
42.01 (C2,CIO), 43.11 (Cs), 45.73 (C9), 47.02 (C3) and 74.36 (Cs). M.S. was identical to an
authentic sample.
Synthesis of pentacyclo[6.3.0.02,6.03,10.05,9]undecane-4-0) (2.53)30,43
Pentacyclo[5.4.0.02,6.03,1o.0s,9]undecane-8-o1 (20.00 g, 0.12 mol) was dissolved 10 a
solution of glacial acetic acid (300 rnI) and concentrated sulphuric acid (7.00 g). The
solution was refluxed, with stirring, for 12 hours. The resulting black solution was cooled,
diluted with deionised water (1200 rnI) and extracted with dichloromethane (500 ml). The
organic extract was washed successively with deionised water, a saturated solution of
sodium hydrogen carbonate and water. Activated charcoal was subsequently added, and
the solution heated for a few minutes. This was filtered, while hot, through celite, which
yielded an orange solution. The solvent was removed in vacuo. The resulting orange oil
was added to a stirring solution of methanol (330 rnI) and potassium carbonate (18.00 g),
and left overnight. The reaction mixture was concentrated in vacuo. Deionised water was
added and extracted with dichloromethane. Removal of the organic solvent yielded
pentacyclo[6.3.0.02,6.03,IO.OS,9]undecane-4-o1 as a white solid (14.00 g, 72 %). m.p. 165°C.
IR (KBr) V max 3412, 2951, 2859cm-
l. IH NMR [CDCh, 300 MHz]: ()H 1.31 (2H, s, 2 x
HII ), 1.44 and 1.48 (2H, AB system, J 10.44 Hz, 2 x H7), 1.54 (1H, S, D20 exchangeable,
OH), 1.91-2.11 (7H, env, HI, H2, H3, Hs, Hs, H9, HIO), 2.56 (1H, s, H6) and 4.15 (1H, S, H4).
13C NMR [CDCh, 300 MHz]: ()e 33.00 (C7 ), 33.68 (C lI ), 40.67 (C 2), 41.23 (C9), 43.14
(C IO), 44.21 (C6), 47.14 (Cs), 47.45 (Cl), 52.22 (Cs), 53.49 (C3), 77.45 (C4). M.S. was
identical to an authentic sample.
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Chromium trioxide (32.00 g, 0.32 mol) was prepared in deionised water (30 ml) and added
to acetic acid (320 ml). The alcohol (20.00 g, 0.12 mol) was dissolved in acetic acid (100
ml) and added drop-wise to the prepared mixture. The reaction was refluxed at 90°C
overnight. The successful oxidation (lones oxidation) of the alcohol was evident through
reduction of Cr6+ (dark red) to Cr3+ (green). The reaction mixture was cooled, diluted with
deionised water (1000 ml) and extracted with dichloromethane (800 ml). The organic
extract was washed successively with water (2 x 500 ml), a saturated bicarbonate solution
(2 x 500 ml) and water (500 ml). The organic solution was dried, using anhydrous sodium
sulphate. The mixture was filtered, and the solvent removed in vacuo to yield
pentacyclo[6.3.0.02,6.03,IO.OS,g]undecanone (15.55 g, 81 %). m.p. 165°C. IR (KEr) V max
3433,2949, 1770, 1750 cm-I. IH NMR [CDCh, 300 MHz]: OH 1.40-1.75 (H7a, H7s, Hila,
13HIIs), 2.35-2.43 (8H, env., HI, H2, H3, Hs, H6, Hg, Hg, H IO). C NMR [CDCh, 300 MHz]:
Oc 35.52 (C7 , Cll ), 40.94 (C 2, Cg), 41.09 (C6, C IO), 47.69 (Cl, Cg), 50.20 (C3 , Cs), 217.45
(C4). M.S. was identical to an authentic sample.
Synthesis of tris-hydantoin (2.12)23
A mixture of the mono-ketone (1.00 g, 6.25xlO-3 mol), NaCN (1.00 g, 2.04x10-2 mol),
(NH4hC03 (2.00 g, 2.08x10-
2 mol), ethanol (10 ml) and NH40H (15 ml) were sealed in a
glass pressure vessel. This was sealed in a metal pressure vessel, containing water. The
reaction was placed in an oil bath and heated at 60°C for two hours, 100°C for two hours
and 120 °C overnight. The cooled reaction was diluted with deionised water (100 ml) and
extracted with ethyl acetate (150 rnI). The solvent was removed in vacuo to yield the crude
hydantion. The product was washed successively with acetone and diethyl ether, thereafter,
recrystallised with tetrahydrofuran to yield pure hydantoin as a white solid (1.32 g, 92 %).
m.p. 325°C. IR (KEr) V max 3314, 2944, 1766, 1720, 1403 cm-I. IH NMR [CDCh, 400
MHz]: OH 1.19-1.22 (1H, Hlls, J 9.89 Hz), 1.24-1.27 (1H, H7s, J 10.26 Hz), 1.36-1.39 (2H,
H7a, Hila, J 10.26 Hz), 1.91 (Hs), 1.97 (H3), 2.10 (HI, Hg), 2.13 (Hg), 2.18 (H2), 2.45 (H6),
2.84 (H IO), 7.88 (D20 exchangeable H!'), 10.54 (D20 exchangeable H3) l3C NMR [CDCh,
400 MHz]: Oc 32.95 (C7 ), 33.49 (Cll ), 42.20 (Cg), 42.75 (C IO), 43.69 (C 2), 45.66 (C6), 46.66
(Cl), 47.10 (Cg), 54.82 (Cs), 55.67 (C3), 73.48 (C4), 157.05 (C2,) and 177.50 (C4,). M.S-
TOF [M+Ht 231 m/z.
Synthesis of 4-amino-(D3)-trishomocubane-4-carboxylic acid (tris-amino
acid, 2.13)23
The hydantoin (1.00 g, 4.35xlO-3 mol) was dissolved in a 1.25 M NaOH solution and
placed in a metal pressure vessel. The vessel was sealed, placed in an oil bath and heated
with stirring at 170°C overnight. The cooled reaction was diluted with deionised water
(100 ml) and placed on a hotplate to reduce the volume to 80 ml. The reaction was
subsequently adjusted to pH 6.5, which induced precipitation of the amino acid. The
volume of the reaction was again reduced to 50 ml. The amino acid was recovered through
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filtration and successively washed with acetone and diethyl ether to yield the amino acid as
a white solid (0.47 g, 52 %). IR (KBr) Vmax 3199,1590,1496 cm-I. The amino acid was
characterised as the Fmoc derivative (2.65).
Improved yield of 4-amino-(D3)-trishomocubane-4-carboxylic acid (tris-
amino acid, 2.13)48
Novel Compound 2 (0.2 g, 4.65x10-4 mol) was added to an aqueous lithium hydroxide (8
mol equivalents) solution and left to stir for 24 hours. The solution was adjusted to pH 6.5
using concentrated HCI. This resulted in the tris-amino acid precipitating out of solution.
The mixture was filtered to isolate the tris-amino acid, which was subsequently washed
with acetone and diethyl ether. This resulted in pure tris-amino acid (0.1 g, 4.87x 10-4 mol).
The infrared spectrum was identical to an authentic sample. The amino acid was
characterised as the Fmoc derivative (2.65).
Synthesis of Fmoc-tris-amino acid (2.65)23
To an ice cooled solution of amino acid (0.10 g, 4.88x10-4 mol) in 1A-dioxane (7.50 ml)
and 10 % (Iv) Na2C03 (20 ml) was added, with stirring, a solution of 9-fluorenylmethyl
chloroformate (Fmoc, 015 g, 5.80x10-4 mol) in lA-dioxane (5.00 ml). This was left to stir
in the ice-bath for four hours and at room temperature for a further eight hours. The
solution was diluted with deionised water (50 ml) and extracted with diethyl ether (100 ml).
The aqueous layer was cooled to 10 QC in an ice-bath and acidified to pH 2 with
concentrated HCI. The solution was subsequently extracted with ethyl acetate (150 ml).
The organic solvent was evaporated in vacuo to give the crude Fmoc derivative.
Purification was achieved through silica gel column chromatography (dichloromethane)
(0.16 g, 75 %). m.p. 213 QC. IR (KBr) Vmax 3360,2952, 1748, 1702, 1294 cm-I. IH NMR
[DMSO, 400 MHz]: OH1.15-1.50 (m, 4H), 1.90-2.30 (m, 7H), 2.47 (m, 1H), 3.35 (s, 1H,
D20 exchangeable), 4.10-4.43 (m, 3H), 7.22-8.08 (m, 8H), 12.17 (s, 1H, D20
exchangeable). 13C NMR [DMSO, 400 MHz]: Oc 31.70 (t), 32.70 (t), 42.50 (d), 42.60 (d),
42.80 (d), 43.80 (d), 46.10 (d), 46.40 (d), 46.70 (d), 52.80 (d), 53.30 (d), 65.10 (s), 68.60
(t), 120.00 (d), 125.10 (d), 125.20 (d), 126.90 (d), 127.90 (d), 140.60 (s), 140.70 (s), 143.70
(s), 143.80 (s), 155.30 (s), 174.00 (s). M.S. was identical to an authentic sample.
Synthesis of Novel Compound 1 (NC1, 2.66)48
A solution of tris-hydantoin (0.50 g, 2.17x 10-3 mol), di-tert-butyl-dicarbonate (0.71 g,
3.26x10-3 mol), 4-dimethyl-aminopyridine (DMAP) (3.00 mg, 2. 17xlO-s mol) in dry THF
(50 ml) was left to stir under nitrogen gas for 24 hours. The solution was concentrated in
vacuo to yield the crude product. Purification was achieved through silica gel column
chromatography (dichloromethane) to yield the product as a white powder (0.53 g, 74 %).
m.p. 206 QC. IR (KBr) Vmax 3220, 1770, 1712 cm-I. IH NMR [CDCl), 400 MHz]: OH 1.26-
1.29 (1H, H 11s, J 10.44 Hz), 1.34-1.37 (1H, H7s, J 10.44 Hz), 1.46-1.49 (2H, H7a, Hila, J
10.44 Hz), 1.56 (9H, Hs'), 2.08 (Hs), 2.09 (H3), 2.18 (HI), 2.19 (Rs), 2.27 (R2), 2.33 (Rg),
75
2.39 (H6), 2.95 (HIO), 6.40 (Hr). I3C NMR [CDCh, 400 MHz]: ()e 27.82 (Cg,), 32.80 (C7),
33.16 (Cll), 41.98 (CIO), 42.78 (C2), 43.20 (C9), 45.32 (C6), 46.69 (Cl), 46.76 (Cg), 55.12
(Cs), 56.08 (C3), 71.78 (C4), 85.31 (CT ), 146.29 (C2), 152.20 (Cs), 171.80 (C4,). M.S.
[M+Ht 331 rn/z. Elemental analysis. Experimental: C, 65.54, H, 6.41, N 8.27 %.
Calculated: C, 65.45, H, 6.67, N, 8.48 %.
Synthesis of Novel Compound 2 (NC2, 2.67)51
A solution of tris-hydantoin (0.50 g, 2.17x10-3 mol), di-tert-butyl-dicarbonate (1.19 g,
5.43xlO-3 mol), 4-dimethyl-aminopyridine (DMAP) (1.3 mg, 1.09x10-
4
mol) and
triethylamine (0.35 ml, 2.60x10-3 mol) in dry THF (50 ml) was left to stir under nitrogen
gas for 24 hours. The solution was concentrated in vacuo to yield the crude product.
Purification was achieved through silica gel column chromatography (dichloromethane) to
yield the product as a white powder (0.77 g, 98 %). m.p. 227°C. IR (KEr) Vmax 2965,
1771 cm-I. IH NMR [CDCh, 400 MHz]: ()H 1.27-1.30 (HI Is, J 11.17 Hz), 1.30-1.33 (H7s, J
11.17 Hz), 1.44-1.46 (HIla, J 7.69 Hz), 1.46-1.48 (H7a, J 8.06 Hz), 1.53 (9H, HI2,), 1.55
(9H, Hg), 2.09-2.13 (HI), 2.14-2.15 (Hg), 2.16-2.17 (Hs), 2.28 (H6), 2.29 (H9), 2.38-2.40
(H2), 2.52-2.53 (H3), 3.12 (HIO)' 13C NMR [CDC13, 400 MHz]: ()e 27.52 (C I2,), 27.72 (Cg,),
32.94 (Cl I), 33.02 (C7), 41.94 (C9), 42.91 (CIO), 45.27 (C6), 45.93 (Cl), 46.11 (Cg), 46.23
(C2), 54.03 (C3), 58.15 (Cs), 76.55 (C4), 84.95 (Cll ,), 86.11 (CT ), 145.74 (C2'), 149.67 (Cs),
149.03 (C9,), 169.59 (C4,). M.S. [M+Ht 431 rn/z. Elemental analysis. Experimental: C,
63.91, H, 6.70, N, 6.39 %. Calculated: C, 64.19, H, 6.98, N, 6.51 %.
Synthesis of Novel Compound 3 (NC3, 3.14)54,56
A solution of isopropanol (0.27 ml, 3.56x10-3 mol) and triphosgene (0.35 g, 1.19x10-3 mol)
in 50 rnl of dry THF was stirred under nitrogen gas in an ice-bath. Once the reaction
mixture had reached 0 QC, dry pyridine (0.58 ml, 7.12xl0-3 mol) was added via cannular
over a 30 s period. A white precipitate of pyridinium hydrochloride was immediately
visible. The reaction was allowed to slowly warm to room temperature and left to stir
overnight. The solution was filtered directly into an ice-cooled, stirred solution of tris-
hydantoin (0.46 g, 2.00xlO-3 mol) and dry THF (50 ml). This was performed under
nitrogen gas. This resulted in a pale yellow solution, which was allowed to warm to room
temperature over 24 hours. The solution was evaporated to dryness in vacuo and the
resulting yellow precipitate was dissolved in dichloromethane (100 ml) and extracted with
deionised water (100 ml). The organic layer was subsequently dried over anhydrous
sodium sulphate and filtered. Evaporation of the organic solvent resulted in the crude
product, which was purified by silica gel column chromatography (dichloromethane). This
resulted in white crystals of product (0.44 g, 70 %). m.p. 175°C. IR (KEr) V max 3304,
1822,1771 cm-I. IH NMR [CDCh, 400 MHz]: ()H 1.25-1.28 (Hlls, J 10.44 Hz), 1.35-1.36
(6H, Hg,), 1.45-1.48 (2H, H7a and HIla, J 10.44 Hz), 2.07-2.08 (Hs), 2.08-2.10 (H3), 2.17-
2.18 (2H, HI and Hg), 2.27-2.30 (H9), 2.30-2.33 (H2), 2.44 (H6), 2.94 (H IO), 5.15 (1H, HT),
6.98 (Hr). I3C NMR [CDCh, 400 MHz]: ()e 21.54, 21.56 (C9,), 32.78 (C ll ), 33.13 (C7),
41.96 (C9), 42.75 (Cg), 43.22 (C2), 45.30 (C6), 46.71 (Cd, 55.22 (Cs), 56.13 (C3), 71.92
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(C4), 72.69 (Cs'), 147.53 (Cs'), 152.46 (C4,), 171.44 (Cz'). M.S. [M+Ht 317 rn/z. Elemental
analysis. Experimental: C, 64.22, H, 6.30, N, 8.72 %. Calculated: C, 64.56, H, 6.33, N,
8.86 %.
Synthesis of Novel Compound 4 (NC4, 3.15)54,56
A solution of R-(-)-2-butanol (0.32 ml, 3.50x10-3 mol) and triphosgene (0.35g, l.17x 10-3
mol) in 50 ml of dry THF was stirred under nitrogen gas in an ice-bath. Once the reaction
mixture had reached 0 QC, dry pyridine (0.57 ml, 7.00xlO-3 mol) was added via cannular
over a 30 s period. A white precipitate of pyridinium hydrochloride was immediately
visible. The reaction was allowed to slowly warm to room temperature and left to stir
overnight. The solution was filtered directly into an ice-cooled, stirred solution of tris-
hydantoin (0.46 g, 2.00x10-3 mol) and dry THF (50 ml). This was performed under
nitrogen gas. This resulted in a pale yellow solution, which was allowed to warm to room
temperature over 24 hours. The solution was evaporated to dryness in vacuo and the
resulting yellow precipitate was dissolved in dichloromethane (100 ml) and extracted with
deionised water (100 ml). The organic layer was subsequently dried over anhydrous
sodium sulphate and filtered. Evaporation of the organic solvent resulted in the crude
product, which was purified by silica gel column chromatography (dichloromethane). This
resulted in white crystals of product (0.48 g, 73 %). m.p. 215 cc. IR (KBr) V max 3439,
1802,1757,1718 cm-I. IH NMR [CDCh, 400 MHz]: ()H 0.94-0.99 (H IO,), 1.26-1.28 (HIIs, J
10.62 Hz), 1.32-1.35 (HT), 1.45-1.48 (2H, H7a and Hlla, J 10.62 Hz), 1.60-1.75 (H9·), 2.07-
2.09 (Hs), 2.09-2.11 (H3), 2.17 (2H, HI and Hs), 2.28-2.31 (Hz), 2.31-2.33 (H9), 2.45 (H6),
13 s;:2.95 (H IO), 5.00 (Hs), 7.19 (Hr). C NMR [CDCh, 400 MHz]: vc 9.45 (C IO'), 19.21, 19.28
(CT ), 28.55, 28.58 (C9'), 32.79 (Cl I), 33.15 (C7), 41.98 (C9), 42.75 (C IO), 43.23 (Cz), 45.34
(C6), 46.73 (Cl and Cs), 55.21, 55.25 (Cs), 56.12, 56.17 (C3), 71.96, 72.00 (C4), 77.32 (Cs'),
147.74 (Cs'), 152.62 (C4'), 171.50 (Cz'). M.S. [M+Ht 331 rn/z. Elemental analysis.
Experimental: C, 65.35, H, 6.79, N, 8.50 %. Calculated: C, 65.45, H, 6.67, N, 8.48 %.
Synthesis of Novel Compound 5 (NC5, 4.10)106
A solution of tris-amino acid (0.41 g, 2.00x10-3 mol) in ethanol was treated with thionyl
chloride (0.50 ml, 6.85x 10-3 mol) and refluxed for 24 hours. The solution was evaporated
to dryness under reduced pressure to yield the crude product. This was extracted with
dichloromethane and deionised water. The organic solvent was removed in vacuo to yield
the amino acid ester, which was purified by silica gel chromatography (dichloromethane) to
yield the pure product (0.33 g, 71 %). m.p. 56 cc. IR (KBr) Vmax 3427, 2954 2869 1730-I I ' ,
cm . H NMR [CDCh, 400 MHz]: ()H 1.25-1.28 (3H, Hs'), 1.30 (H7s,H IIs), 1.37-1.39 (HIla,
J 11.72 Hz), 1.39-1.42 (H7a, J 11.72 Hz), 1.80 (HI', DzO exchangeable protons), 1.94-1.95
(H3), 2.07-2.10 (Hs), 2.10-2.11 (HI, Hs, H IO,), 2.12-2.15 (H9), 2.15-2.18 (Hz), 2.60 (H6),
4.12-4.18 (H4'). 13C NMR [CDCI3, 400 MHz]: ()c 14.19 (Cs), 32.68, 33.60 (C7, C Il ), 42.10
(Cz), 43.22 (CIQ), 44.64 (C6), 46.91, 46.92 (Cl, Cs), 54.04 (Cs), 56.20 (C3), 60.47 (C4'),
69.07 (C4), 175.74 (Cz'). M.S. [M+Ht 234 rn/z. Elemental analysis. Experimental: C,
72.37, H, 8.27, N, 6.08 %. Calculated: C, 72.10, H, 8.15, N, 6.01 %.
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Hydrolysis of Novel Compound 5 (NC5) using PLE63,70
PLE (12 mg) was added to a stirring suspension of NCS (0.20 g, 8.58xlO-4 mol) in 0.05 M
KH2P04 buffer (11.00 ml) of pH 8 and 25°C. The pH was maintained by adding 0.1 M
NaOH dropwise and the temperature was maintained by an electronic probe. The reaction
was run over a two-week period. The mixture was filtered through a sintered glass funnel
and washed with buffer solution. The resulting solution was extracted with ethyl acetate
(100 ml). The aqueous layer was acidified to pH 6.5 with concentrated HCI. The volume
was reduced by heating on a heating mantle, which resulted in the amino acid precipitating
out of solution. The amino acid was recovered by filtration and washed successively with
acetone and diethyl ether (17.50 mg, 10 %). The IR spectrum was identical to that of tris-
amino acid. The Fmoc derivative was subsequently synthesised. The NMR data was
identical to previously synthesised Fmoc-tris-amino acid.
Coupling of linker to MBHA resin (5.22)23,91
The MBHA resin (0.50 f' 0.70 mmol NH2/g) was swelled using DMF. The FmocAM
linker (0.47 g, 8.75xl0- mol), DIPCDI (0.14 ml, 8.75xlO-4 mol) and HOBt (0.12 g,
8.75xl0-4 mol) were added at room temperature to the resin in DMF. This was left to stir
for 24 hours. Successful attachment was confirmed by a negative Kaiser test. The Fmoc
group was cleaved by the application of a 20 % Clv) piperidine in DMF solution for two
hours. Cleavage of the Fmoc group was confirmed by positive Kaiser test. The Fmoc by-
product was removed from the solution by filtration, followed by washing the resin with
isopropanol and DMF.
Washing procedure for solid phase peptide synthesis23,91
The resin was washed with DMF (5 x 10 ml), isopropanol (3 x 10 ml) and DMF (3 x 10
ml).
Coupling of glycine and alanine to the linker (5.24, 5.25)23,91
The Fmoc protected amino acid, DIPCDI (0.14 ml, 8.75xlO-4 mol) and HOBt (0.12 g,
8.75xlO-4 mol) were added at room temperature to the resin in DMF. This was left to stir
for 24 hours. Successful attachment was confirmed by a negative Kaiser test. The Fmoc
group was cleaved by the application of a 20 % CV/v) piperidine in DMF solution for two
hours. Cleavage of the Fmoc group was confirmed by positive Kaiser test. The Fmoc
group was removed from the solution by filtration, followed by washing the resin with
isopropanol and DMF.
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Synthesis of Fmoc-tris-acid fluoride23,89
Cyanuric fluoride (40.50 ul, 4.68x10-4 mol) was added to a suspension of Fmoc-tris-amino
acid (0.20 g, 4.68x 10-4 mol) and dry dichloromethane (50 ml). Dry pyridine was
subsequently added (37.80 ul, 4.68x 10-4 mol) and the resulting solution was left to stir
under nitrogen for 12 hours. The mixture, which now contained a white suspension of
water-soluble cyanuric acid was extracted with ice water (40 ml). The organic phase was
dried over MgS04, filtered and subsequently removed in vacuo. The resulting white solid
was recrystallised from dichloromethanelhexane to give the pure acid fluoride as a white
solid (0.17 g, 87 %). IR (KBr) V max 2966,1724,1504,1277 cm-I. IH NMR [CDCh, 300
MHz]: OH 1.16-1.18 (m, 4H), 1.96-2.46 (m, 7H), 2.73 (br s, 1H), 4.22 (t, J 6.6 Hz, 1H), 4.75
(d, J 6.2 Hz, 2H), 5.38 (s, 1H, D20 exchangeable), 7.25-7.48 (m, 4H), 7.59 (d, J 7 Hz, 2H),
7.77 (d, J 7Hz, 2H). l3C NMR [CDCh, 300 MHz]: Oc 32.00 (t), 33.0 (t), 42.7 (d), 42.9 (d),
43.2 (d), 44.2 (d), 46.9 (d), 47.0 (d), 47.2 (d), 53.7 (d), 54.1 (d), 66.7 (t), 68.1 (s), 69.2 (s),
119.3 (d), 124.8 (d), 127.0 (d), 127.6 (d), 141.3 (s), 143.5 (s), 155.2 (s), 158.6 (s), 166.0 (s).
19F NMR [CDCh, 400 MHz]: OF 234.09. M.S. and infrared spectra were identical to an
authentic sample.
Coupling of Fmoc-tris-acid fluoride to the dipeptide (5.26)23
The tris-amino acid fluoride (0.67 g, 1.56x10-3 mol) and dry pyridine (151.00 ul, 1.87x 10-3
mol) was added to the resin in DMF and left to stir for 24 hours. Successful attachment
was confirmed by a negative Kaiser test. The Fmoc group was cleaved by the application
of a 20 % Clv) piperidine in DMF solution for two hours. The Fmoc group was removed
from the solution by filtration, followed by washing the resin with isopropanol and DMF.
Cleavage of the tripeptide from the resin and Iinker (5.27)23,91
The resin was washed several times with dichloromethane, methanol and diethyl ether and
dried overnight in a vacuum pump. The dry resin was placed in a flask containing the
cleavage mixture of 95 % (Iv) trifluoroacetic acid, 2.5 % (Iv) water and 2.5 % Clv)
triisopropylsilane. The mixture was left to stir for 12 hours. The resin was removed by
filtration and washed several times with TFA. The application of nitrogen gas served to
evaporate the TFA. Diethyl ether was subsequently added to precipitate the tripeptide as a
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Spectrum 6: Infrared spectrum (KBr) of dione (2.19)
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Spectrum 7: IH NMR spectrum of the keto-ketal in CDCh (2.31)
91










~~-_. -- --- r~~ at. ..-~.





















I i j i i i I i i i ! ~"""'-r-·T""I·l·--r-r:r'l-"..r-t~"r--r-TJ'-'''''-I''''-''I''rT".-r-:r--r:r""c-rrt~
380036003400 3200 3000 2800 2600 2400 2200 2000 1800,' 1600 1400' i,:OO 1OOO~OC
. Ilavenullbers (cIlH)
~- ----,~._._- - ---_ ...__._--_._-----..-....----..- .......---








































(oT~ 1Iv HO H ! 1,
--"~ r-Tt--t" r-"l -IT""'-"T'"#rr-r-r r j or IT-Or-r"rTi" rOl--rr--r-l-T,,-·\T" -r""-:--:--"-r-rl-' --'i ~!J~j~,~r!'~~~~~~~
140 120 100 BD 60












I I r I I I I. I I I p' I I I , I I I I I . I I I I '. I fit If' • , j I , J • I I I _, I. I I ~ I I t I I • I , , I I j , I' I ,































































3800 3600 3400 3200 3000 2800 2600 2400 2200 2000 1800 1600 1400 1200 1000 800 600
Navenulbers (cll-1)




'I 'I , , IrTTTT' i i i I i i i i I' t r i J ..-r-'
110 100 90 80
'-r'--.T 56TT1 ~'I , t i" 16 iPPM i I , irr
I
i






















3BOO 3600 3400 3200 3000 2BOO 2600 2400 2200 2000 lBOO 1600 1400 1200 1000 BOO 600
lIavenumbers (eIH)


















~3800_. _36_00_34_00_3200__3000__2800__2600_.;;~~~S ~~)._1800 1600 1400 1200 ~~ 800 600 I









































!"':'''!-'''-~-l-r''''''i'I!'~(''-' l",-rrt','ri ';" rrT"r'rrt f-r-, ri" t'." 1-T"r' n- J -rT·t-'("Ir'-rJ'-r'-' ·r..··;,t"l ..tl·rTIr~l"-'··'fT'-I~ '-rrr-rrr--1-' ~'-r











































h~ I' , , I' ,. I ' , , I' , 1.1' , '1' , , I ' , , ,':,.......,..,.-,-, , , I ' , , I' , 'J r , '" , , I ',' , I' ~
4000 3BOO 3600 3400 3200 3000 2800 2600 2400 2200 2000 1800 1600 1400 1200 1000 800 600
Mlvenumbers (c.-1)__ .. __ I


























































































r--'---.-----.---'---,--,.-' • l 1 • I , 1 , ' • , , 1--'- r---," , I T I , T I--T --. I I I I
10 S 11 7 6 5 4 3 Z 1 pp.



























































I ! I I I I I I I , I I I , I I I I f I I ' I , • I I , I • I ' 0 0 , I I , 0 0 I I I 0 I 0 ~ I 0 \ rT·' T T-ro:-. I ' I; o. I I I 0 I 1000' I i" 0 I
ZaD 1111 161 141 HI 111 III 61 4D ZI pp.
Spectrum 26: 13C NMR spectrum of tris-hydantoin in [(CD3hSO] (2.12)
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Spectrum 28: NOESY spectrum of tris-hydantoin in [(CD3hSO] (2.12)
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Spectrum 37: IH NMR spectrum of Novel Compound 1 in CDCh (2.66)
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Spectrum 40: NOESY spectrum of Novel Compound 1 in CDCh (2.66)
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Spectrum 45: IH NMR spectrum of Novel Compound 2 in CDCI3 (2.67)
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Spectrum 48: NOESY spectrum of Novel Compound 2 in CDCh (2.67)
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Spectrum 49: HSQC spectrum of Novel Compound 2 in CnCl3 (2.67)
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Spectrum 52: Mass spectrum (FAB) of Novel Compound 2 (2.67)
136
IND[)C FREQUENCY 'PM HEIGHT
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Spectrum 54: 13C NMR spectrum of Novel Compound 3 in CDCh (3.14)
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Spectrum 56: NOESY spectrum of Novel Compound 3 in CDCh (3.14)
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Spectrum 57: HSQC spectrum of Novel Compound 3 in CDCh (3.14)
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Spectrum 65: HSQC spectrum of Novel Compound 4 in CDCh (3.15)
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Spectrum 68: Mass spectrum (FAB) of Novel Compound 4 (3.15)
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Spectrum 70: BC NMR spectrum of Novel Compound 5 in CDCh (4.10)
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Spectrum 72: NOESY spectrum of Novel Compound 5 in CDCh (4.10)
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Chromatogram 82: HPLC chromatogram of alanine-glycine from an 80 % C/v) acetonitrile/20 %
C/v) water/O.l % C/v) trifluoroacetic acid (solution A) and 100 % water (solution B)
gradient system: 80 % solution A and 20 % solution B was changed linearly to
40 % solution A and 60 % solution Bat 1.00 ml min-1 over 30 minutes.
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Chromatogram 84 : HPLC chromatogram of alanine-glycine-tris-amino acid from an 80 % (Iv)
acetonitrile/20 % (Iv) water/O.l % (Iv) trifluoroacetic acid (solution A) and
100 % water (solution B) gradient system: 80 % solution A and 20 %
solution B was changed linearly to 40 % solution A and 60 % solution
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Spectrum 85 : Mass spectrum (FAB) of alanine-glycine-tris-amino acid
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Appendix 2
Commands for Gaussian 98
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1.1 Commands for Gaussian 98
1.1.1 TS
This command is used to request the use of a mathematical search algorithm, which
aims to find a local maximum on the potential energy surface (transition state) rather
than a local minimum for a normal optimisation.
1.1.2 Opt
This instruction requests that a geometry optimisation is performed.
1.1.3 Modredundant (modred)
MODRED is used in conjunction with a geometry optlmlsation, specifying the
specific co-ordinates that are to be constrained during a SCAN calculation, while the
remaining co-ordinates are optimised. Bonds, bond angles and dihedral angles can be
used as reaction co-ordinates. These co-ordinates could also be fixed for the duration
of a calculation using MODRED.
1.1.4 Noeigentest
The default algorithm in G98
1
uses a test to determine the number of negative
eigenvalues. If more than one negative eigenvalue is found, the program
automatically terminates the calculation since it assumes the wrong negative
eigenvalue (solution of the wave function) might be followed to produce a wrong
result. Since there can be only one true transition state, there can only be one negative
eigenvalue associated with a transition state. The problem is, except when the starting
structure of the transition state calculation is very close to the real transition state, that
more than one negative eigenvalues will in practice be found. The result is that very
few transition state optimisations proceed to the end. To avoid this, one should turn
the default eigentest off by using the "noeigentest" command.
Note that some programs have better algorithms to find transition states. For
exapmple, once a frequency calculation is performed, one is allowed to choose the
negative eigenvalue representing the correct transition state. The software code will
then ensure that the wave function involving the correct transition is solved.
1.1.5 GDIIS
This specifies the use of the modified GDIIS algorithm, which is recommended
during the processing of large systems and molecules with a flat potential energy
surface. It makes use of a smaller step size down (for local minima) or up (for local
maxima) the potential energy surface.
1.1.6 SCAN Calculation
This is used to find a starting structure for a transition state optimisation. This
command changes the specified reaction co-ordinate in a number of steps as the
reaction proceeds from reactants to products. The rest of the molecule is optimised to
find the lowest possible energy for the structure. A plot of energy for each step versus
reaction co-ordinate reveals the approximate transition state as a maximum on the
graphical plot.
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1) Gaussian 98, Revision A9, Frisch, M.J., Trucks, G.W., Schlegel, H.B.,
Scuseria, G.E., Robb, M.A, Cheeseman, J.R., Zakrzewski, V.G.,
Montgomery, Jr., J.A., Stratmann, R.E., Burant, J.e., Dapprich, S., Millam,
lM., Daniels, AD., Kudin, KN., Strain, M.C., Farkas, 0., Tomasi, J., Barone,
V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, e., Adamo, C., Clifford, S.,
Ochterski, J., Petersson, G.A, Ayala, P..Y., Cui, Q., Morokuma, K, Malick,
D.K, Rabuck, AD., Raghavachari, K, Foresman, lB., Cioslowski, l, Ortiz,
J.V., Baboul, A.G., Stefanov, B.B., Liu, G., Liashenko, A, Piskorz, P.,
Komaromi, I., Gomperts, R., Martin, R.L., Fox, DJ., Keith, T., AI-Laham,
M.A, Peng, C.Y., Nanayakkara, A., Challacombe, M., Gill, P.M.W., Johnson,
B., Chen, W., Wong, M.W., Andres, J.L., Gonzalez, e., Head-Gordon, M.,
Replogle, E.S., Pople, J.A, Gaussian, Inc., Pittsburgh PA, 1998.
Appendix 3
Cartesian Co-ordinates for Computational Structures
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Co-ordinates for DFT optimised tris-hydantoin (2.64)
b3Iyp/6-31 +g(d) opt=restart pop=full gfprint (-763.8105618a.u.)
C, -1.193546, -1.403636, 0.496093
C, -0.891161, -2.489253, 1.533748
C, 0.628165, -2.381062, 1.383295
C, 0.852441, -2.682643, -0.115436
C, -0.226862, -1.699572, -0.724913
H, -2.247028, -1.248678, 0.244792
H, -1.273089, -3.481868, 1.265200
H, -1.267945, -2.229058, 2.530479
H, 0.728032, -3.732304, -0.398852
C, 2.204906, -2.027448, -0.402094
H, 3.012677, -2.443774, 0.212198
H, 2.514125, -2.067504, -1.454145
C, 1.760368, -0.624815,0.026381
C, 0.578788, -0.344953, -0.922938
C, -0.260558, 0.712219, -0.171861
C, -0.463708, -0.171892, 1.075969
C, 0.943735, -0.830101, 1.368207
H, 2.521080, 0.154277, 0.069321
H, 0.843428, -0.095543, -1.954853
H, 1.442419, -0.446812, 2.259233
H, 1.244072, -2.971636, 2.068083
H, -0.954883, 0.308859, 1.926364
H, -0.722467, -2.070265, -1.625700
C, 0.417790, 2.072839, 0.079528
0, 1.437748,2.299520,0.704021
N, -1.491666, 1.135580, -0.842689
N, -0.379402, 3.017749, -0.532949
C, -1.527634, 2.472647, -1.138217
0, -2.361761, 3.090376, -1.774725
H, -0.190255, 4.012088, -0.523548
H, -2.096927, 0.505752, -1.350046
Co-ordinates for volume of trishomocubane
rhf/3-21+g scf=tight volume (-422.3703658a.u.)
C, 1.322402, -0.267346, -2.830973
H, 2.298043, -0.683981, -2.691547
C, 0.149199, -1.096494, -2.260161
H, 0.017948, -2.092609, -2.628166
C, -1.051231, -0.230749, -2.519923
174
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H, -1.305937, -0.192595, -3.558465
C, -0.539657, 1.099767, -1.930207
H, -0.860945, 1.981966, -2.443431
C, 0.994831, 0.898842, -1.870980
H, 1.567056, 1.798256, -1.963241
C, -2.117852, -0.777121, -1.538807
H, -3.047457, -0.247545, -1.521966
H, -2.357605, -1.808960, -1.689559
C, -1.201262, -0.471554, -0.333444
H, -1.538941, -0.764441, 0.638714




C, 1.132022, 0.280398, -0.504048
C, 0.227070, -0.980963, -0.723937
H, 0.549807, -1.865501, -0.215672
H, 2.138763, 0.052904, -0.221879
H, 1.230799, -0.048935, -3.874431
H, 0.654031, 2.209622, 0.400311
Co-ordinates for the transition state of the protonated
trishomocubanol (6.11)
rhf/3-21 +g opt=(ts,noeigentest,gdiis) freq optcyc=100 (-499.8554894a.u.)
C, -0.474635, 1.324753, -0.826928
C, 0.677770,1.380022,0.151918
C, 1.442904,0.058812, -0.073580
C, 0.254694, -0.906222, -0.399822
C, -0.789669, 0.013453, -1.025284
C, -0.303281, -1.322013, 1.011100
C, -1.747103, -0.839010, 1.046624
C, 0.449607, -0.324306, 1.910838
C, -0.167186,1.018588,1.402229
C, -1.485350,0.618241,0.669702
C, 1.867329, -0.321635, 1.342003
H, -1.001231, 2.162047, -1.246146
H, 1.263939, 2.285564, 0.177544
H, 2.207064, 0.106145, -0.837415
H, 0.499273, -1.735508, -1.046520
0,0.214749, -0.364864, -3.823040
H, -1.599631, -0.317980, -1.644527
H, -0.147017, -2.361694,1.262736
H, -2.159256, -0.845112, 2.052810
H, -2.434839, -1.363467,0.397525
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H, 2.344664, -1.292863, 1.407584
H, 0.862896, -0.977619, -4.149309
H, -0.149789, 0.051372, -4.594978
Co-ordinates for the transition state of the exo-endo PCU diol (6.12)
rhf/3-21+g opt=(ts,noeigentest,gdiis) freq optcyc=100 (-670.7193615a.u.)
C, 0.277999,1.160234,0.813842
C, -1.180608, 0.857513, 0.493741
C, -1.275256, -0.686625, 0.530150
C, 0.154448, -1.088204, 0.022189
C, 1.035410,0.037537,0.525443
C, 0.052360, -0.933975, -1.548480
C, 1.005827,0.188213, -1.953730
C, -1.336328, -0.267330, -1.700732
C, -1.056132,1.129099, -1.039633
C, 0.504767,1.298177, -1.037514
C, -2.195398, -0.996872, -0.656251
H, 0.640171, 2.029405, 1.312894
H, -1.912700, 1.384351, 1.075277
H, -1.522624, -1.080560, 1.500536
H, 0.506106, -2.046343, 0.361695
0, 1.231124, -1.054399, 2.766029
H, 2.094293, -0.015337, 0.608997
H, 0.169106, -1.861817, -2.090626
H, 0.833286, 0.496501, -2.981181
H, -1.713758, -0.232584, -2.712904
H, -1.606879, 1.961314, -1.449794
H, 0.951705, 2.267258, -1.168301
H, -3.183018, -0.565394, -0.540430
H, -2.290254, -2.056389, -0.865367
H, 1.660372, -1.481369, 3.513244
H, 0.565963, -0.308412, 3.047806
F, -0.339679, 0.771126,3.108325
0,2.410429, -0.069878, -1.747387
H, 2.810395, -0.623140, -2.430065
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Co-ordinates for the transition state of the exo-exo PCU diol (6.13)
rhf/3-21 +g opt=(tS,noeigentest,gdiis) freq optcyc=100 (-670.7166734a.u.)
C, -0.551659, 1.059959, -0.892533
C, 0.922343, 1.030033, -0.502997
C, 1.330895, -0.459618, -0.609924
C, -0.009707, -1.171069, -0.214521
C, -1.074214, -0.212142, -0.720282
C, -0.029481, -1.093770, 1.364082
C, -1.231437, -0.236541, 1.734898
C, 1.180437, -0.170646,1.641947
C, 0.664498, 1.173559, 1.032763
C, -0.894726, 1.032712,0.926738
C, 2.224911, -0.651049, 0.621354
H, -1.050414, 1.862048, -1.386648
H, 1.561529, 1.726409, -1.011820
H, 1.705815, -0.738508, -1.579722
H, -0.142370, -2.156761, -0.624760
0, -1.065282, -1.112417, -2.961138
H, -2.100040, -0.458654, -0.876656
H, 0.011306, -2.048842, 1.864317
H, 1.471581, -0.123194, 2.677668
H, 1.005718,2.071367, 1.522641
H, -1.524263, 1.889839, 1.093946
H, 3.109999, -0.026044, 0.590937
H, 2.522067, -1.680903, 0.784193
H, -1.337861, -1.629737, -3.724807
H, -0.508221, -0.257526, -3.209223
F, 0.201809, 0.924425, -3.214789
H, -2.190444, -0.682443, 1.515757
0, -1.135263, 0.071147, 3.146738
H, -1.937474, 0.454721,3.523330
Co-ordinates for transition state in Chapter 6, Figure 6.10, letter 'a'
rhf/gen opt=(ts,noeigentest,gdiis) freq optcyc=100 (-3131.8607671)
C, 0.996524, 0.079265, -2.382304
H, 2.005893, -0.209895, -2.146795
C, -0.057108, -0.976491, -2.032221
H, 0.035081, -1.891521, -2.602561
C, -1.400389, -0.228206, -2.261659
H, -1.717121, -0.205753, -3.291183
C, -1.071853,1.160476, -1.649689
H, -1.637021,1.989779, -2.042176
C, 0.489825, 1.281402, -1.602797
H, 0.931513, 2.215299, -1.908727
C, -2.352504, -0.861328, -1.238690
H, -3.289722, -0.323619, -1.142950
H, -2.558531, -1.907726, -1.432526
C, -1.450130, -0.640322, -0.021326
H, -1.779459, -0.972132, 0.947038
C, -1.108403, 0.888721, -0.105560
H, -1.663460, 1.521829, 0.562117
C, 0.485276, 1.026433, -0.053706
H, 0.895232, 1.774316,0.599383
C, 0.776612, -0.369077, 0.324300
H, 1.105671, -0.616552, 1.307717
C, -0.067019, -1.282267, -0.484885
H, 0.030158, -2.325625, -0.235617
0, 2.899350, -0.677013, -0.090258
H, 3.301841, -1.429085,0.368418
Br, -0.062800, 0.108678, 3.299199
H, 3.451277,0.114431,0.000286
0,0.897493,0.451797, -3.786600
H, 1.266910, -0.207387, -4.388283
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Co-ordinates for transition state in Chapter 6, Figure 6.10, letter 'b'
rhf/gen opt=(ts,noeigentest,gdiis) freq optcyc=400 (-3131.86866a.u.)
C, 1.604054,0.361154, -1.921991
C, 0.622315, -0.738146, -2.346894
H, 1.094133, -1.535712, -2.900509
C, -0.456498, 0.047535, -3.135189
H, -0.189017, 0.256484, -4.160366
C, -0.627645, 1.305388, -2.232022
H, -0.984491, 2.194277, -2.726420
C, 0.652175, 1.404350, -1.335960
H, 1.087539,2.377191, -1.175533
C, -1.748496, -0.746211, -2.906467
H, -2.637251, -0.223389, -3.244021
H, -1.724739, -1.737487, -3.342112
C, -1.653434, -0.758023, -1.376876
H, -2.425715, -1.267848, -0.823868
C, -1.455073, 0.761382, -1.017972
H, -2.330654, 1.286400, -0.678817
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C, -0.137854, 0.869410, -0.091138
H, -0.183472,1.466110,0.798721
C,-0.012284, -0.568155, 0.131874
H, -0.188120, -0.980977, 1.109110
C, -0.174993, -1.320752, -1.120250
H, -0.124692, -2.391017, -1.018850
0,2.084779, -0.505340, 1.533183
H, 2.783434, -1.080968, 1.870703
Br, -0.513469, 0.060861, 3.356557
H, 1.485154, -0.211303, 2.270295
H, 2.067953, 0.766142, -2.811093
0,2.673087, -0.079391, -1.084302
H, 2.504825, -0.077791, -0.120471
Co-ordinates for the transition state of the 8-exo-fluoro-ll-exo-
hydroxy-PCU (6.16)
rhf/3-21 +g opt=(ts,noeigentest,gdiis) freq optcyc=100 (-770.2721304a.u.)
C, -0.027602, -1.135451, 0.627338
C, 1.287802, -0.510605, 0.179253
C, 1.023766, 1.015285,0.215314
C, -0.488604, 1.070493, -0.204157
C, -1.045539, -0.253275, 0.317035
C, -0.452545, 0.965029, -1.775146
C, -1.205949, -0.312279, -2.110739
C, 1.028374,0.596757, -2.018860
C, 1.086787, -0.812958, -1.341668
C, -0.406202, -1.295894, -1.228483
C, 1.774203, 1.506436, -1.028798
H, -0.137492, -2.064132,1.141614
H, 2.173036, -0.856938, 0.678051
H, 1.233182, 1.482870, 1.164032
H, -1.043924,1.899146,0.196894
F, -1.854918, 0.933012, 2.286082
H, -2.079234, -0.446986, 0.493303
H, -0.790993, 1.842378, -2.303720
H, -2.266068, -0.279578, -1.910770
H, 1.332158,0.619215, -3.051663
H, 1.749865, -1.527992, -1.800772
H, -0.642318, -2.340478, -1.330322
H, 2.837931, 1.304641, -0.979185
H, 1.620318,2.558759, -1.237181




H, -0.407277, 0.552291, 4.862727
H, -1.084382, 0.639545, 3.227798
0, -0.956565, -0.643379, -3.495716
H, -1.586697, -1.268397, -3.875863
Co-ordinates for the transition state of the 8-exo-fluoro-ll-endo-
hydroxy-PCU (6.17)
rhf/3-21 +g opt=(ts,noeigentest,gdiis) freq optcyc=100 (-770.2726247a.u.)
C, -0.015637, 1.172843,0.536305
C, -1.365376, 0.569235, 0.170825
C, -1.111643, -0.958191, 0.163633
C, 0.369480, -1.015094, -0.358215
C, 0.972029, 0.287116, 0.148791
C, 0.224869, -0.877061, -1.921998
C, 0.927012, 0.422440, -2.308603
C, -1.271087, -0.506494, -2.054319
C, -1.276054,0.899477, -1.352868
C, 0.223615, 1.375531, -1.348424
C, -1.951797, -1.427871, -1.029662
H, 0.135773, 2.096801, 1.047474
H, -2.207146, 0.913760, 0.739865
H, -1.260410, -1.436342, 1.118187
H, 0.939710, -1.860866, -0.019490
F, 1.792719, -1.105568, 2.105642
H, 2.017526, 0.461584, 0.243733
H, 0.523720, -1.753980, -2.478443
H, 0.673137, 0.725290, -3.320889
H, -1.658866, -0.519363, -3.062797
H, -1.975800, 1.620158, -1.745918
H, 0.470684, 2.418137, -1.431198
H, -3.008167, -1.221026, -0.903680
H, -1.817750, -2.477028, -1.265730
F, -1.014418, 1.291330,2.931891
0, 0.365355, -0.378982, 3.806298
H, -0.380264, 0.494860, 3.442838
H, 0.461308, -0.600333,4.733373
H, 1.130327, -0.794305, 3.010161
0, 2.353530, 0.462062, -2.124447
H, 2.847965, -0.055438, -2.772894
Appendix 4
Compact Disk
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